ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	41/1308	57/5488	1.689810599604e-14	6.46606236461105e-12	5.20713767787237e-12	6356/6357/6362/6363/6347/6364/6367/6369/6370/6348/6351/6355/1440/6376/2919/3627/6373/2920/2921/6374/6372/4283/10148/3589/3606/3552/3553/3557/11009/90865/3569/3976/4049/4312/4314/4318/5008/6696/7040/7124/10673	41
WP2806	Complement system	48/1308	73/5488	2.43085051301167e-14	6.46606236461105e-12	5.20713767787237e-12	133/335/715/716/717/718/719/720/722/728/729/811/958/1604/966/22918/629/1675/3426/5199/1378/2159/2160/2214/2219/2357/2769/2771/3383/3384/3673/3687/3689/3690/3818/3911/3915/5648/5329/5806/6401/6402/6403/6404/710/6696/7097/7454	48
WP5055	Burn wound healing	52/1308	91/5488	6.73166237708021e-12	1.19374812820222e-09	9.61328627183034e-10	8038/6347/57124/1139/1265/1277/1278/2919/3579/2006/2200/2261/60674/3082/3383/3552/3553/3569/3624/3791/3956/23643/440823/4312/4322/4313/79148/4314/4318/100463486/64332/64127/5159/6282/6280/871/6423/6678/6876/7040/7043/7076/7096/7097/7099/10333/51311/54106/3371/7124/7128/7431	52
WP5115	Network map of SARS-CoV-2 signaling pathway	81/1308	180/5488	1.9590657755239e-10	2.60555748144678e-08	2.09826255431112e-08	59272/183/335/8542/332/684/11119/715/716/84433/838/841/6356/6347/6364/6367/6348/6351/6355/891/1234/9332/914/10666/983/1051/629/3426/5199/1294/1508/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/54541/1958/84985/2247/2534/51512/3091/3122/3123/3429/10964/8519/10410/3486/3606/8807/3552/3553/90865/3569/10379/3699/3717/3726/3932/116844/64386/4791/22861/114548/4939/5743/6241/6288/6289/6403/5054/6772/7124/7535	81
WP5218	Extrafollicular B cell activation by SARS-CoV-2	36/1308	62/5488	6.8392382754268e-09	7.27694952505411e-07	5.86014732231307e-07	57379/604/718/720/6363/958/969/973/941/3732/1378/10148/2113/83416/1880/29851/3433/8519/3455/3569/3662/9636/3687/3689/4240/5133/639/5788/6402/57823/6776/30009/7099/7124/10673/7494	36
WP2877	Vitamin D receptor pathway	58/1308	127/5488	4.13117937327901e-08	3.66297904430739e-06	2.94980702618344e-06	5243/11096/240/248/604/768/838/875/898/958/1030/1045/634/9075/1493/1594/1559/1565/29785/1576/1673/11221/1946/50486/727936/3091/3123/6927/3294/3486/3488/9173/3662/3684/3726/3827/126364/4600/5368/639/10125/6275/6279/6280/1992/10568/219855/25928/6696/79689/412/6822/7040/7056/7078/7128/4982/54210	58
WP3624	Lung fibrosis	29/1308	48/5488	6.057675695046e-08	4.60383352823496e-06	3.70747971110334e-06	23250/6356/6347/6348/6351/729230/1051/1440/2920/57105/1906/2006/2247/2252/26585/3082/3553/3569/4313/4318/4502/5155/5328/5806/6498/6696/7040/7076/7124	29
WP2911	miRNA targets in ECM and membrane receptors	17/1308	22/5488	1.78504888606781e-07	1.18705750923509e-05	9.55940653459998e-06	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/3672/22801/3694/3910/3913/3915/7058	17
WP558	Complement and coagulation cascades	27/1308	45/5488	2.13432945598463e-07	1.23382620046786e-05	9.93603608212149e-06	715/716/717/718/719/721/728/729/1604/629/1675/3426/1191/1378/2159/2149/2152/3818/3827/5648/5328/5329/5054/5345/710/7056/7450	27
WP455	GPCRs, class A rhodopsin-like	43/1308	88/5488	2.31922218133057e-07	1.23382620046786e-05	9.93603608212149e-06	1238/57007/51554/150/187/719/1230/729230/1233/1234/10803/1131/1240/3577/3579/2833/10800/57105/1909/2149/2151/9002/2867/2357/2358/8477/8111/8843/1241/5540/27334/53829/9934/5030/5031/5724/5729/5737/266747/6751/6752/56670/2829	43
WP2328	Allograft rejection	36/1308	70/5488	4.56351320679102e-07	2.20708093273893e-05	1.77736830159229e-05	5243/717/718/720/721/729/841/6363/940/958/1604/941/942/1289/1493/6373/4283/50943/10578/3002/3108/3111/3112/3119/3122/3123/3134/3552/3553/3559/120892/5551/6772/7040/7124/7431	36
WP129	Matrix metalloproteinases	16/1308	21/5488	5.86784383034e-07	2.40130224441606e-05	1.93377525420922e-05	4312/4319/4321/4322/4323/4327/4313/10893/64386/79148/4314/4316/4318/7076/7078/7124	16
WP2865	IL1 and megakaryocytes in obesity	16/1308	21/5488	5.86784383034e-07	2.40130224441606e-05	1.93377525420922e-05	6347/2149/2205/1839/3383/3606/3553/3554/4318/114548/7941/6280/8991/7076/7096/7097	16
WP2882	Nuclear receptors meta-pathway	93/1308	250/5488	8.86755713447571e-07	3.36967171110077e-05	2.71360582987339e-05	5243/1244/64240/64241/57007/51/177/241/51129/335/345/8553/330/874/6347/6364/983/8824/23491/1545/1557/1559/1576/1551/66002/1907/1958/54566/1969/2168/9982/2289/2938/2939/2947/2949/1839/3082/3589/3553/3726/23764/4199/4240/4791/1728/8431/9971/3084/5105/5142/5155/5166/5460/10891/9588/22949/5743/6286/6319/6397/5272/1836/6513/6514/6515/11182/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/8140/5552/27286/6774/2040/6817/6822/7040/7056/7124/7128/84951/1831/54658/7364	93
WP619	Type II interferon signaling	21/1308	33/5488	1.24493836994821e-06	4.41538141874966e-05	3.55571871276437e-05	4261/3627/4283/1536/2633/3383/3433/3553/3659/3662/10379/9636/3717/4843/5698/5967/8651/9021/6688/6772/6890	21
WP5198	Inflammatory bowel disease signaling	20/1308	31/5488	1.63450825755251e-06	5.4347399563621e-05	4.37661092647284e-05	50943/3108/3594/3595/3606/8807/3552/50615/3569/4772/64127/6097/6772/6774/6775/30009/7040/7097/7099/7124	20
WP691	Tamoxifen metabolism	12/1308	14/5488	1.79760091034662e-06	5.6254334370847e-05	4.5301769071893e-05	1545/1557/1558/1559/1565/1576/2326/6817/6783/6822/54575/7364	12
WP5090	Complement system in neuronal development and plasticity	39/1308	84/5488	4.23749484645239e-06	0.000125241514350704	0.00010085733347989	57194/23250/57198/715/716/717/718/719/720/721/722/725/728/729/843/841/1604/966/629/1675/3426/5199/1191/1378/286204/6376/9787/2219/3684/3685/3687/3689/3690/5648/4240/5359/710/7040/7043	39
WP4462	Platelet-mediated interactions with vascular and circulating cells	12/1308	15/5488	7.03044680429446e-06	0.000196852510520245	0.000158525864229798	6347/958/3383/3553/6401/6403/6404/7040/7043/7097/7099/7412	12
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	88/1308	244/5488	7.64697325774531e-06	0.000196864090992047	0.00015853519001536	10000/285/1101/1277/1278/1280/1281/1282/1284/1286/1289/1290/50509/1292/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2247/2252/2254/2261/2321/2324/2690/59345/2786/3082/3091/7184/3455/3559/3560/3563/3575/22801/3673/3678/3655/3679/8516/3683/3685/3687/3689/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/4843/4846/5008/9180/5155/5159/5209/5228/23035/5293/5294/23533/10891/5523/5618/6513/6514/6515/6696/7010/7058/3371/7424/7450	88
WP5088	Prostaglandin signaling	17/1308	26/5488	7.77095096021236e-06	0.000196864090992047	0.00015853519001536	834/6347/6348/729230/940/2919/3627/4283/3552/3553/3569/4318/114548/5294/9536/7040/7124	17
WP4172	PI3K-Akt signaling pathway	92/1308	259/5488	9.70817344512114e-06	0.000231877262999409	0.000186731393036722	10000/285/672/898/1101/1277/1278/1280/1282/1284/1285/1286/1291/1292/1293/256076/64764/84699/9586/1440/1441/54541/1942/1946/1969/2149/2247/2252/2254/2261/2321/2324/2690/59345/10681/2786/3082/7184/3455/3559/3560/3563/3569/3575/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3717/3718/3791/284217/3909/3910/3911/3913/3915/3918/10319/4170/4846/5008/9180/5105/5106/5155/5159/5228/23035/118788/5293/5294/8503/23533/29941/5523/5618/10110/6696/7010/7058/7097/7099/3371/7424/7450	92
WP453	Inflammatory response pathway	16/1308	24/5488	1.00247688890722e-05	0.000231877262999409	0.000186731393036722	940/958/941/942/1277/1278/1281/3559/3560/3911/3913/3915/3918/3932/7133/7535	16
WP24	Peptide GPCRs	17/1308	27/5488	1.63402509910742e-05	0.000350214448675731	0.000282028651782791	719/728/1230/729230/1233/1234/10803/3577/3579/2833/10663/1909/2357/2358/5540/6751/6752	17
WP3937	Microglia pathogen phagocytosis pathway	21/1308	37/5488	1.64574458964159e-05	0.000350214448675731	0.000282028651782791	10095/1536/2207/2209/3055/3684/3689/4067/653361/4688/4689/3071/5293/5294/8503/5336/5880/27036/54210/7409/10451	21
WP4493	Cells and molecules involved in local acute inflammatory response 	12/1308	16/5488	2.20068746996582e-05	0.000450294513085314	0.000362623400921493	718/729/3383/3552/3569/3683/3689/3827/6403/6404/7124/7412	12
WP4891	COVID-19 adverse outcome pathway	10/1308	12/5488	2.34211353073998e-05	0.000453774594664312	0.00036542592011946	59272/183/6347/6348/1440/3627/3553/3559/3569/7124	10
WP5063	FOXP3 in COVID-19	11/1308	14/5488	2.38828734033848e-05	0.000453774594664312	0.00036542592011946	940/941/942/50943/3559/3560/3569/3572/3575/6774/6776	11
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	16/1308	26/5488	4.39981311216419e-05	0.000807138129541845	0.000649990539619175	6347/29126/941/942/1493/3627/3559/3560/4791/5133/8651/6774/7040/7043/7099/51311	16
WP4538	Regulatory circuits of the STAT3 signaling pathway	31/1308	68/5488	6.30150006628214e-05	0.00111746601175403	0.000899898430518186	1271/1438/1439/1441/1844/2149/2151/9002/2690/3455/3587/3595/3601/50615/9466/3559/3560/3563/3572/3575/3717/3718/5600/6300/9180/5159/5579/5788/80854/9021/6774	31
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	14/1308	22/5488	7.95128782720462e-05	0.00132190160127277	0.00106453096897115	51/8309/246/240/66002/8529/10800/57105/1800/2358/2687/1241/22949/8989	14
WP4969	RAS and bradykinin pathways in COVID-19	14/1308	22/5488	7.95128782720462e-05	0.00132190160127277	0.00106453096897115	1636/59272/183/1576/3552/3553/3816/3818/3827/4846/4881/5054/710/7124	14
WP2849	Hematopoietic stem cell differentiation	22/1308	43/5488	8.88620634944787e-05	0.00143256417512311	0.00115364784185814	91/947/4261/1440/2313/10320/3552/3553/3569/3690/51176/4005/4582/3071/399/861/23541/6688/6776/7068/23650/7409	22
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	19/1308	35/5488	9.5509008958934e-05	0.00149443508135744	0.00120347265158781	285/597/332/664/1906/3091/3485/3486/3939/4170/4843/5315/5366/5743/5054/6566/6513/6515/7043	19
WP4494	Selective expression of chemokine receptors during T-cell polarization	13/1308	20/5488	0.000105365125176055	0.00160154990267604	0.00128973250967382	6348/6351/1230/729230/1233/1234/940/2833/3594/3595/8809/7040/7043	13
WP5094	Orexin receptor pathway	41/1308	101/5488	0.000121439976622567	0.00179461298786683	0.00144520673933874	8553/2920/1734/1846/1958/1959/1960/2324/84662/1839/3091/8091/3309/3383/3553/3569/3726/3777/3939/3949/4023/84230/23764/7873/4322/4314/4846/3164/8013/26031/5069/5163/6241/861/6401/6498/6513/6696/3371/7124/7412	41
WP545	Complement activation	12/1308	18/5488	0.000137659685384469	0.00197932304390642	0.00159395425182017	715/716/717/718/720/721/729/1604/629/1675/5199/5648	12
WP5033	Genes associated with the development of rheumatoid arthritis	11/1308	16/5488	0.000176311424623579	0.002405068664096	0.00193680836226172	958/4261/1493/3123/3559/3572/3685/26147/6583/6775/7185	11
WP530	Cytokines and inflammatory response	11/1308	16/5488	0.000176311424623579	0.002405068664096	0.00193680836226172	1440/2919/2920/3122/3123/3589/3552/3553/3569/7040/7124	11
WP2431	Spinal cord injury	36/1308	87/5488	0.0001974441564286	0.00262600728050038	0.00211473083332737	301/6347/729230/983/50515/1280/1282/1464/2919/3627/2920/1958/2212/2697/3383/3552/3553/3554/3569/10288/1241/4321/4318/4843/3164/5320/5362/5743/6403/57556/7040/7099/7124/10673/1462/7431	36
WP474	Endochondral ossification	25/1308	54/5488	0.000236720954350148	0.00290347992214792	0.00233818030928809	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/864/871/55553/6696/6772/7040/7078	25
WP4808	Endochondral ossification with skeletal dysplasias	25/1308	54/5488	0.000236720954350148	0.00290347992214792	0.00233818030928809	9510/9507/11096/249/50515/1280/4921/5167/2247/2261/2487/2690/3157/3549/4256/4322/4318/5328/864/871/55553/6696/6772/7040/7078	25
WP2880	Glucocorticoid receptor pathway	27/1308	60/5488	0.000241896917580198	0.00290347992214792	0.00233818030928809	57007/241/51129/8553/330/6347/6364/1907/54566/9982/3589/4240/8972/4791/5142/5460/5743/6286/6397/5272/1836/5552/2040/7056/7128/84951/1831	27
WP3945	TYROBP causal network in microglia	27/1308	60/5488	0.000241896917580198	0.00290347992214792	0.00233818030928809	54518/718/8832/64764/79690/202309/3059/3142/10261/3587/3606/3684/3687/3689/4688/3071/375387/5341/170954/5996/864/64092/6696/6776/10312/113277/7133	27
WP3929	Chemokine signaling pathway	52/1308	140/5488	0.000245595106196722	0.00290347992214792	0.00233818030928809	196883/10000/6356/6363/6364/6367/6369/6370/6348/6351/1230/729230/1233/10803/6376/3627/6373/2921/6374/4283/3579/2833/10663/1794/9844/2268/2771/59345/10681/2786/2869/3055/3702/3717/3718/4067/653361/5293/5294/8503/23533/23236/57580/5579/5880/25759/6772/6774/7409/10451/7454/2829	52
WP5109	Familial hyperlipidemia type 2	9/1308	12/5488	0.000260770338815602	0.00295169830318937	0.00237701070320157	335/337/338/1071/2053/2690/3949/4023/255738	9
WP697	Estrogen metabolism	9/1308	12/5488	0.000260770338815602	0.00295169830318937	0.00237701070320157	1545/1576/2938/1728/412/6817/6783/54658/7364	9
WP3617	Photodynamic therapy-induced NF-kB survival signaling	17/1308	32/5488	0.000315290563903618	0.00349447041659843	0.00281410656817483	597/330/332/2920/3383/3552/3553/3569/4312/4313/4314/4318/4791/5743/6401/7124/7412	17
WP702	Metapathway biotransformation Phase I and II	41/1308	105/5488	0.00032843274664112	0.00356584124924645	0.00287158169458509	50515/9435/9469/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/1576/1551/66002/8529/260293/9420/2052/2053/2326/2330/9514/79690/2938/2939/2947/2949/9953/8514/9027/4837/6817/6799/6783/6822/54658/54575/79799/7364	41
WP4754	IL-18 signaling pathway	77/1308	228/5488	0.000337394377527419	0.00358987617689174	0.00289093708744546	35/11096/321/467/330/841/6362/6363/6347/6364/6348/6351/890/9308/1051/1071/9076/24146/1277/1278/1281/2920/2921/1674/1891/2023/338442/3315/26353/3383/8870/3606/8809/8807/3553/3559/3569/3659/3801/10365/3932/4312/4322/4323/4313/4314/4318/653361/4688/4791/64332/4843/8431/3164/7941/5579/5743/5778/5806/6004/8698/9021/6696/30009/7052/7076/7078/55858/7124/7127/7128/4982/79931/7185/10194/80149/51222	77
WP117	GPCRs, other	15/1308	27/5488	0.00037607937317025	0.00392302404954065	0.00315922197895339	1234/1131/3577/3579/2833/1909/2149/29933/11245/1880/59352/53829/5737/1901/6752	15
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	9/1308	13/5488	0.000668123726666401	0.00683541966512548	0.00550458212051063	302/335/338/1071/3949/9388/4023/4547/255738	9
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	17/1308	34/5488	0.000791959468657785	0.00780226735788781	0.00628318720747989	9744/9447/84674/834/838/841/50506/3606/3553/4210/4671/58484/22861/114548/64127/639/8767	17
WP43	Oxidation by cytochrome P450	17/1308	34/5488	0.000791959468657785	0.00780226735788781	0.00628318720747989	51700/1545/56603/1593/1594/1557/1558/1559/1565/1573/29785/1576/1551/66002/8529/260293/9420	17
WP229	Irinotecan pathway	8/1308	11/5488	0.000832736275192774	0.00805483088004647	0.00648657730150161	4363/1244/9429/590/8824/1576/54658/54575	8
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	20/1308	43/5488	0.000912443740496001	0.00866821553471201	0.006980537638757	2180/2182/9023/1593/1717/60481/3992/9415/2222/2224/3157/3158/51478/3422/4047/6307/4597/6319/8435/6713	20
WP1533	Vitamin B12 metabolism	17/1308	35/5488	0.00120229001988904	0.0112213735189644	0.0090366027349001	335/338/875/6347/8029/3383/3553/3569/3949/4791/6288/6289/5054/6648/6947/6948/7124	17
WP306	Focal adhesion	59/1308	173/5488	0.00124472345183418	0.0114171185582031	0.00919423674948293	10000/330/857/858/1101/1277/1278/1280/1282/1284/1286/1290/50509/1292/2268/2316/2318/2321/2534/3055/3082/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/3791/284217/3909/3910/3911/3913/3915/3918/10319/29780/64098/5155/5159/5228/5293/8503/5579/5880/25759/6696/10420/7058/3371/7409/10451/7424/7450/7791	59
WP272	Blood clotting cascade	9/1308	14/5488	0.00147595571642509	0.0133086176464093	0.0107174661299735	2159/2160/2152/3816/3818/5328/5054/5345/7450	9
WP430	Statin inhibition of cholesterol production	12/1308	22/5488	0.00181465355375317	0.0158693646226601	0.0127796426620947	64240/64241/335/337/338/345/1071/2222/3949/4023/4547/6713	12
WP98	Prostaglandin synthesis and regulation	18/1308	39/5488	0.00181960759771102	0.0158693646226601	0.0127796426620947	301/302/306/307/308/309/1906/1909/3290/4286/10891/5729/5730/9536/5737/5740/5743/6916	18
WP167	Eicosanoid synthesis	10/1308	17/5488	0.00207776886340394	0.0178285973440467	0.0143574181223328	246/240/241/1800/5320/5730/9536/5740/5743/6916	10
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	24/1308	58/5488	0.00221823461614874	0.0187317589808116	0.0150847366545119	59272/841/6347/6348/6351/11126/2919/3627/6373/2920/2921/6374/6372/4283/3579/84868/3433/8519/3455/3569/3902/6772/7040/7124	24
WP197	Cholesterol biosynthesis pathway	9/1308	15/5488	0.0029135936351133	0.0238466432904657	0.0192037669553216	1717/2222/2224/3157/3422/4047/6307/4597/6713	9
WP497	Urea cycle and metabolism of amino groups	9/1308	15/5488	0.0029135936351133	0.0238466432904657	0.0192037669553216	445/1152/2628/162417/4942/4953/5009/5831/6723	9
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	12/1308	23/5488	0.00298015771485581	0.0240218773379286	0.0193448834122219	51/8309/66002/8529/5729/5730/9536/5737/5740/22949/5743/6916	12
WP465	Tryptophan metabolism	15/1308	32/5488	0.00358476398874473	0.0284640961494358	0.0229222143506537	216/8854/316/1545/1573/1576/66002/9420/1644/23498/3620/8942/4129/6999/7166	15
WP4210	Tryptophan catabolism leading to NAD+ production	8/1308	13/5488	0.00407033922199626	0.0318444186191472	0.0256443972655182	23498/3620/8564/8942/10135/349565/23475/6999	8
WP4541	Hippo-Merlin signaling dysregulation	34/1308	94/5488	0.00456766454795546	0.0352173556451059	0.0283606326623627	84962/960/1009/1012/1001/1003/1004/3627/1969/2261/2321/2324/2305/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/3791/26524/5159/5577/6788/7004/7010	34
WP5097	CCL18 signaling pathway	14/1308	30/5488	0.00509740270798855	0.038740260580713	0.031197637626336	467/960/1278/3091/3939/440823/4313/4318/6513/6772/7004/7412/7424/7431	14
WP4478	LTF danger signal response pathway	9/1308	16/5488	0.00526306271942507	0.0394359065737203	0.0317578432439734	177/3552/3553/3569/4057/7097/7099/7124/54210	9
WP15	Selenium micronutrient network	22/1308	55/5488	0.00544477210696674	0.0402308161236987	0.0323979860750799	240/241/335/338/875/6347/1734/3383/3553/3569/8564/8942/3949/4791/10549/5743/6288/6289/5054/6648/7124/7498	22
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	10/1308	19/5488	0.00613643193417487	0.044321936350099	0.0356925763642467	2919/2920/2247/3553/3976/5155/5354/6469/55553/7124	10
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	24/1308	62/5488	0.00616508137200625	0.044321936350099	0.0356925763642467	857/6347/958/1594/1673/2113/10964/3569/9636/5600/6300/4791/64127/4939/23236/5333/5336/5579/91543/6772/7097/7099/51311/7124	24
WP2884	NRF2 pathway	38/1308	110/5488	0.00682381702651044	0.048403608774714	0.0389795583128386	1244/177/874/8824/23491/1958/1969/2938/2939/2947/2949/1839/3082/23764/4199/1728/3084/5155/9588/22949/6513/6514/6515/11182/55630/283375/115584/159963/6527/200010/11254/340024/6532/6533/23657/7040/54658/7364	38
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	36/1308	104/5488	0.00803095630647831	0.0562166941453482	0.0452714572955218	8553/720/721/1051/1139/1390/1644/1958/54738/2305/2697/3091/7184/3552/3553/3557/3569/3764/4128/4760/4791/5354/5452/5460/10891/5577/864/6507/6532/6750/6751/6752/7068/7124/7166/7433	36
WP75	Toll-like receptor signaling pathway	30/1308	84/5488	0.00912963584775099	0.0630774840390069	0.0507964701303439	10000/841/6348/6351/958/941/942/3627/6373/4283/3455/3553/3569/23643/1326/5600/6300/5293/5294/8503/23533/6696/6772/7096/7097/7099/10333/51311/54106/7124	30
WP236	Adipogenesis	36/1308	105/5488	0.00949138527264751	0.0647361149365189	0.0521321701210194	183/651/1051/1675/1271/56603/1879/1959/2487/3091/6927/3569/3572/8609/3976/23175/4023/10135/7025/5008/5105/5106/10891/5618/5740/6319/5054/8651/9021/6772/6774/6776/7040/7124/57761/25937	36
WP5122	Prostaglandin and leukotriene metabolism in senescence 	12/1308	26/5488	0.0103529742378813	0.0697187632221882	0.0561447103906423	246/240/241/10800/3488/5600/23236/5730/9536/5740/5743/6916	12
WP3942	PPAR signaling pathway	19/1308	48/5488	0.0107538445456401	0.0708615865191001	0.0570650291121364	51/8309/2180/2182/51129/335/345/364/1593/2168/2172/9415/3158/4023/4199/4312/5105/5106/6319	19
WP4724	Omega-9 fatty acid synthesis	7/1308	12/5488	0.0107890761429457	0.0708615865191001	0.0570650291121364	2180/2182/60481/79071/3992/9415/6319	7
WP5130	Th17 cell differentiation pathway	22/1308	58/5488	0.011171465146598	0.0724782860730507	0.0583669616773479	915/50943/3091/3108/3553/50615/9466/3559/3569/3662/3717/3932/4772/6097/861/9021/6772/6774/6776/30009/7040/7535	22
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	8/1308	15/5488	0.0128048584800659	0.0810974370404171	0.0653079874860502	249/1594/5167/56975/2261/4791/142680/6696	8
WP516	Hypertrophy model	8/1308	15/5488	0.0128048584800659	0.0810974370404171	0.0653079874860502	467/11072/1839/3606/3552/3554/8013/6935	8
WP5193	Cholesterol synthesis disorders	9/1308	18/5488	0.0140081382454045	0.0876744652535906	0.0706044862647633	1717/2222/2224/3157/3422/4047/6307/4597/6713	9
WP2876	Pregnane X receptor pathway	12/1308	27/5488	0.0146745386242723	0.0885394255638868	0.071301041164428	5243/1244/1557/1559/1576/1551/66002/2939/10891/27286/6822/54658	12
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	12/1308	27/5488	0.0146745386242723	0.0885394255638868	0.071301041164428	59272/6347/2939/2977/3553/3569/4312/4314/1728/5593/23657/7124	12
WP3613	Photodynamic therapy-induced unfolded protein response	11/1308	24/5488	0.0147944394572228	0.0885394255638868	0.071301041164428	440/467/811/51726/4189/9695/7184/3309/6783/57761/7494	11
WP2879	Farnesoid X receptor pathway	6/1308	10/5488	0.015477756724514	0.0885394255638868	0.071301041164428	1576/2289/8431/9971/10891/6822	6
WP2881	Estrogen receptor pathway	6/1308	10/5488	0.015477756724514	0.0885394255638868	0.071301041164428	51/1545/8431/5105/5166/6774	6
WP5108	Familial  hyperlipidemia type 1	6/1308	10/5488	0.015477756724514	0.0885394255638868	0.071301041164428	51129/335/337/1071/3949/4023	6
WP5110	Familial hyperlipidemia type 3	6/1308	10/5488	0.015477756724514	0.0885394255638868	0.071301041164428	335/337/1071/3949/4023/7436	6
WP5188	Retinol metabolism	6/1308	10/5488	0.015477756724514	0.0885394255638868	0.071301041164428	216/316/1551/10170/9227/195814	6
WP3646	Hepatitis C and hepatocellular carcinoma	18/1308	47/5488	0.0186121859072805	0.10322796413524	0.0831297613831475	330/332/672/960/1284/3577/2487/3091/6927/3569/51176/4312/4843/5420/5743/6241/6774/7040	18
WP2855	Dopaminergic neurogenesis	7/1308	13/5488	0.01862760255072	0.10322796413524	0.0831297613831475	216/1644/4760/4929/6469/6774/7040	7
WP5174	Ulcerative colitis signaling	7/1308	13/5488	0.01862760255072	0.10322796413524	0.0831297613831475	50943/3108/4772/64127/7040/7097/7124	7
WP3529	Zinc homeostasis	12/1308	28/5488	0.0202364952607812	0.10824420056056	0.0871693502733433	4493/4494/4495/4496/4500/4499/4501/4502/55532/7782/55630/283375	12
WP716	Vitamin A and carotenoid metabolism	12/1308	28/5488	0.0202364952607812	0.10824420056056	0.0871693502733433	64240/64241/216/8854/56603/4023/9227/29881/5915/5948/195814/6817	12
WP3287	Overview of nanoparticle effects	8/1308	16/5488	0.0203466542407067	0.10824420056056	0.0871693502733433	10000/1001/1282/3569/3909/5293/5743/7124	8
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	8/1308	16/5488	0.0203466542407067	0.10824420056056	0.0871693502733433	914/2534/3122/3123/3569/3932/64386/7535	8
WP4585	Cancer immunotherapy by PD-1 blockade	10/1308	22/5488	0.0211879446359107	0.110509672022593	0.0889937406276125	10538/29126/915/3123/3932/4772/5133/80380/6774/7535	10
WP5092	Interactions of natural killer cells in pancreatic cancer	10/1308	22/5488	0.0211879446359107	0.110509672022593	0.0889937406276125	6347/6348/6351/10666/2214/3002/4277/5551/201633/7124	10
WP5083	Neuroinflammation and glutamatergic signaling	33/1308	100/5488	0.0227554034788204	0.11672423349495	0.0939983439502266	27185/2247/2752/2893/116443/3587/3552/3553/3554/3569/3572/3976/84230/80131/4049/4791/26227/23236/5579/29968/6505/6507/6509/6513/6515/92745/9021/6772/6774/7040/7043/7124/7133	33
WP534	Glycolysis and gluconeogenesis	15/1308	38/5488	0.022818271209539	0.11672423349495	0.0939983439502266	229/230/2023/2026/2203/3099/3101/3939/5105/5214/5313/5315/6513/6514/6515	15
WP2289	Drug induction of bile acid pathway	6/1308	11/5488	0.0272728590188951	0.131901463618656	0.106220608810434	5243/1244/1576/9971/123264/6822	6
WP4495	IL-10 anti-inflammatory signaling pathway 	6/1308	11/5488	0.0272728590188951	0.131901463618656	0.106220608810434	644/3587/3552/3569/6772/6774	6
WP4707	Aspirin and miRNAs	6/1308	11/5488	0.0272728590188951	0.131901463618656	0.106220608810434	283120/114614/4597/4846/5163/5743	6
WP4723	Omega-3 / omega-6 fatty acid synthesis	6/1308	11/5488	0.0272728590188951	0.131901463618656	0.106220608810434	51/2180/2182/60481/3992/9415	6
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	6/1308	11/5488	0.0272728590188951	0.131901463618656	0.106220608810434	1240/2358/1241/5163/5293/5294	6
WP554	ACE inhibitor pathway	6/1308	11/5488	0.0272728590188951	0.131901463618656	0.106220608810434	1636/59272/183/3827/4846/7040	6
WP2848	Pluripotent stem cell differentiation pathway	11/1308	26/5488	0.0285521914148032	0.135622909220315	0.109217499114896	3577/2247/3082/3589/3569/3624/5155/6469/7040/7043/7474	11
WP4545	Oxysterols derived from cholesterol	11/1308	26/5488	0.0285521914148032	0.135622909220315	0.109217499114896	23597/8309/9023/1593/1576/9420/1717/2053/1880/3638/6097	11
WP4197	Immune response to tuberculosis	10/1308	23/5488	0.0296705029135756	0.136328154723382	0.109785435244195	3437/8519/3455/3659/10379/3717/5696/8651/6772/6890	10
WP4900	Purinergic signaling	10/1308	23/5488	0.0296705029135756	0.136328154723382	0.109785435244195	2771/5026/5027/27334/53829/9934/5030/5031/286530/24145	10
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	7/1308	14/5488	0.0297256878720156	0.136328154723382	0.109785435244195	3589/3569/3572/3717/3718/6774/6935	7
WP4582	Cancer immunotherapy by CTLA4 blockade	7/1308	14/5488	0.0297256878720156	0.136328154723382	0.109785435244195	940/941/942/1493/3123/5293/8503	7
WP3877	MYD88 distinct input-output pathway	8/1308	17/5488	0.0305689972924914	0.13899749196244	0.111935059811462	3552/92610/7096/7097/7099/10333/51311/54106	8
WP4329	miRNAs involvement in the immune response in sepsis	14/1308	36/5488	0.0312874168397115	0.139904938654874	0.112665829110672	6348/6351/3002/3383/3552/3569/3659/3934/114614/4791/7099/51311/7124/7412	14
WP5087	Malignant pleural mesothelioma	100/1308	356/5488	0.0312945257517482	0.139904938654874	0.112665829110672	72/9510/177/84962/10000/285/467/672/834/6347/6351/898/29126/960/1009/1012/1001/1003/1004/1282/1284/1285/1286/1440/115908/2919/3627/6374/80319/1942/1946/1969/2247/2252/2254/2261/2321/2324/2305/1839/3082/3091/3620/3553/3569/3672/3673/3655/3685/3689/3690/3791/9493/284217/3909/3910/3911/3913/3915/3918/10319/26524/51176/9064/11184/9448/4170/4323/4313/4314/4318/114548/5155/5159/5163/5228/5293/5294/5328/5420/10891/9770/83593/6401/5176/6423/6425/6513/8140/6678/6772/6788/7004/7010/7040/29128/7424/7481/7474/25937	100
WP2875	Constitutive androstane receptor pathway	10/1308	24/5488	0.0402962625252561	0.178646763861969	0.143864726734906	5243/1244/1557/1559/1576/2939/10891/6817/6822/54658	10
WP247	Small ligand GPCRs	6/1308	12/5488	0.0437566418948444	0.187992001371335	0.151390472018468	5724/5729/5737/1901/1903/8698	6
WP5171	Leukotriene metabolic pathway	6/1308	12/5488	0.0437566418948444	0.187992001371335	0.151390472018468	4363/240/241/1800/2687/22949	6
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	8/1308	18/5488	0.0438176845301609	0.187992001371335	0.151390472018468	332/3315/3569/3791/4318/6696/6774/7099	8
WP5044	Kynurenine pathway and links to cell senescence	8/1308	18/5488	0.0438176845301609	0.187992001371335	0.151390472018468	23498/3620/8564/8942/23475/6999/7099/7124	8
WP5098	T-cell activation SARS-CoV-2	25/1308	76/5488	0.0451647978030435	0.192221379449753	0.154796401733378	84433/6363/940/915/941/942/1493/2534/3122/3123/29851/3455/3594/3595/8809/3717/3932/3937/4049/4772/5293/10125/6775/7124/7535	25
WP289	Myometrial relaxation and contraction pathways	36/1308	118/5488	0.0563466983733016	0.237908282020607	0.191588189122253	57007/196883/133/467/800/1265/2697/59345/10681/2786/2869/2980/2981/3485/3486/3488/3489/3553/3569/23764/4846/5142/5570/5333/5336/5577/5579/10266/10268/5996/10636/6004/64407/10287/5999/8490	36
WP3925	Amino acid metabolism	24/1308	74/5488	0.0570602412955837	0.239024002907484	0.192486682198944	126/216/440/445/586/875/1644/2752/84706/3067/3158/3939/4128/4357/4942/4953/5009/5105/5166/5315/5831/6723/6999/7166	24
WP727	Monoamine transport	8/1308	19/5488	0.0603449649699064	0.250808760656173	0.201976979792368	183/3553/3554/3690/6532/6999/7124/4982	8
WP176	Folate metabolism	16/1308	46/5488	0.061571068015894	0.25392099367795	0.204483269542789	335/338/875/6347/3383/3553/3569/3949/10797/4791/6288/6289/5054/113235/6648/7124	16
WP3413	NOTCH1 regulation of endothelial cell calcification	7/1308	16/5488	0.063341781972733	0.257235328316748	0.207152312277239	249/813/2261/2702/3672/4256/55553	7
WP3967	miR-509-3p alteration of YAP1/ECM axis	7/1308	16/5488	0.063341781972733	0.257235328316748	0.207152312277239	1277/1281/1289/1909/6678/7004/7058	7
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5/1308	10/5488	0.0650660685960561	0.259234144992373	0.20876196480391	1116/3572/4318/9021/6774	5
WP5111	Familial hyperlipidemia type 4	6/1308	13/5488	0.0652958184755226	0.259234144992373	0.20876196480391	335/337/1071/3949/4023/4547	6
WP5178	Disorders of fructose metabolism	6/1308	13/5488	0.0652958184755226	0.259234144992373	0.20876196480391	216/229/2203/3795/6514/6652	6
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	17/1308	50/5488	0.0670722686073964	0.264314421475073	0.212853125327176	10000/898/1003/1277/1278/2321/3082/3791/4313/4318/4791/5361/5362/91584/55630/7040/7043	17
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	17/1308	51/5488	0.0791480367364965	0.307930898349091	0.24797759324907	308/602/332/2113/2149/3309/3315/8870/3575/1728/3084/8767/9021/7124/7185/10451/7431	17
WP4496	Signal transduction through IL1R	11/1308	30/5488	0.079297994499672	0.307930898349091	0.24797759324907	3552/3553/3554/3556/3557/3569/3656/11213/7040/7043/7124	11
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	15/1308	44/5488	0.0805930690301813	0.310692121188815	0.250201213541448	695/6356/2534/3055/3559/3569/3575/3717/3932/4067/4791/6772/6774/6775/6776	15
WP4018	Clear cell renal cell carcinoma pathways	25/1308	81/5488	0.0886927308919041	0.339457070751748	0.273365705967474	229/230/1012/2023/2026/2321/3091/3099/3101/3791/8844/3939/4199/5155/5159/5214/26227/5313/5315/29968/6513/6774/7040/7043/6935	25
WP69	T-cell receptor signaling pathway	26/1308	85/5488	0.0917359082569174	0.344576461547728	0.277488365354027	84433/1234/940/915/9308/2534/29851/3601/3552/3553/3569/3662/3702/3932/3937/1326/11184/4772/8767/7040/3604/7409/10451/7431/7454/7535	26
WP12	Osteoclast signaling	6/1308	14/5488	0.0919734164281529	0.344576461547728	0.277488365354027	1513/8111/3690/5155/6696/4982	6
WP3935	Leptin-insulin signaling overlap	6/1308	14/5488	0.0919734164281529	0.344576461547728	0.277488365354027	3717/5294/8503/8651/9021/6774	6
WP1539	Angiogenesis	9/1308	24/5488	0.0948205606527526	0.349906516603112	0.281780673243899	2247/2321/3091/3791/4318/4846/5155/7010/7078	9
WP2406	Cardiac progenitor differentiation	9/1308	24/5488	0.0948205606527526	0.349906516603112	0.281780673243899	290/2247/3624/3670/3791/3084/5460/7040/7070	9
WP4747	Netrin-UNC5B signaling pathway	15/1308	45/5488	0.095369257344833	0.349906516603112	0.281780673243899	116986/249/6347/1003/1277/2534/3383/3552/3635/3791/59277/54538/6401/7124/7412	15
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	19/1308	60/5488	0.102696257096712	0.374208279283908	0.301350949086962	941/9076/1285/1286/1378/1514/1759/2534/3685/3690/3911/3913/4288/4311/5329/5420/7040/7099/7431	19
WP4595	Urea cycle and associated pathways	8/1308	21/5488	0.103685763220472	0.375243714512186	0.302184787903561	8659/445/162417/4843/4846/4942/5009/5831	8
WP4136	Fibrin complement receptor 3 signaling pathway	12/1308	35/5488	0.107069274044017	0.382667162445791	0.308162910794295	6347/3627/2921/3569/3656/3684/3689/23643/4843/83593/7099/7124	12
WP2374	Oncostatin M signaling pathway	20/1308	64/5488	0.107175577451923	0.382667162445791	0.308162910794295	6347/1051/1958/3091/3572/3717/3718/3726/3949/4312/4322/4314/5008/9180/5579/5054/9021/6772/6774/7078	20
WP3893	Development and heterogeneity of the ILC family	7/1308	18/5488	0.113305942797192	0.40185841045404	0.323617675217243	6927/3606/3553/90865/3569/30009/7124	7
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	9/1308	25/5488	0.118199075880942	0.416436479262656	0.335357433834391	1390/2555/2562/2564/2568/3717/5294/8503/6774	9
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	5/1308	12/5488	0.134277387064294	0.46997085472503	0.378468812570414	2222/2224/3157/3422/4597	5
WP4816	TGF-beta receptor signaling in skeletal dysplasias	16/1308	51/5488	0.135613602146177	0.471545335567098	0.379736746291668	81794/25805/2022/2200/3624/3694/51176/3976/864/5054/6498/6696/6772/6774/7040/7124	16
WP4298	Acute viral myocarditis	22/1308	74/5488	0.144716634675184	0.499930192514271	0.402595149096375	834/841/857/1234/1604/941/1906/2534/3108/3569/3683/3689/4318/4791/64127/5880/8651/6772/6774/7040/7099/7124	22
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	10/1308	30/5488	0.155979223071406	0.535360946283792	0.431127631851016	59272/3455/10379/4939/4940/6772/7097/7099/10333/54106	10
WP299	Nuclear receptors in lipid metabolism and toxicity	8/1308	23/5488	0.160328359220355	0.543278261816746	0.437503467668017	5243/1244/64240/1594/1559/1576/9971/5915	8
WP5036	Angiotensin II receptor type 1 pathway	8/1308	23/5488	0.160328359220355	0.543278261816746	0.437503467668017	59272/183/1277/1278/3091/3589/3572/7040	8
WP286	IL-3 signaling pathway	14/1308	45/5488	0.164159534249685	0.552739697600205	0.445122787738986	969/942/1439/2534/3055/3563/3635/3717/4067/5293/6774/6776/7040/7409	14
WP4658	Small cell lung cancer	26/1308	91/5488	0.171500637124056	0.57382603113206	0.462103669708644	10000/330/841/898/1030/1282/1284/1285/1286/3673/3655/3685/284217/3909/3910/3911/3913/3915/3918/10319/4843/5293/8503/5743/5915/7185	26
WP1434	Osteopontin signaling	5/1308	13/5488	0.177390867432277	0.578968966097983	0.466245289279539	3685/3690/4318/5328/6696	5
WP3591	Sleep regulation	5/1308	13/5488	0.177390867432277	0.578968966097983	0.466245289279539	100/3606/3569/5729/5730	5
WP4760	PKC-gamma calcium signaling pathway in ataxia	5/1308	13/5488	0.177390867432277	0.578968966097983	0.466245289279539	773/2769/2893/5163/23236	5
WP698	Glucuronidation	5/1308	13/5488	0.177390867432277	0.578968966097983	0.466245289279539	5238/54658/54575/79799/7364	5
WP364	IL6 signaling pathway	13/1308	42/5488	0.181001641705957	0.587151666997373	0.472834840656768	183/3055/3569/3572/3659/3717/3726/639/9021/6772/6774/7076/7409	13
WP241	One-carbon metabolism	8/1308	24/5488	0.193082258504157	0.618793744121756	0.498316291764058	10840/275/55349/2346/2745/25902/10797/6948	8
WP581	EPO receptor signaling	8/1308	24/5488	0.193082258504157	0.618793744121756	0.498316291764058	3717/5163/5294/5788/8651/6772/6774/6776	8
WP2436	Dopamine metabolism	4/1308	10/5488	0.197371284638802	0.625009068022871	0.503321509072633	1644/4128/4129/1728	4
WP5176	Disorders of bile acid synthesis and biliary transport	4/1308	10/5488	0.197371284638802	0.625009068022871	0.503321509072633	1244/8309/1593/9420	4
WP185	Integrin-mediated cell adhesion	24/1308	85/5488	0.200898421065596	0.632413964537853	0.509284692455295	10000/827/857/858/2534/3672/22801/3673/3678/3655/3679/8516/3683/3684/3685/3687/3689/3690/3694/6300/5880/7145/10451/7791	24
WP2583	T cell receptor and co-stimulatory signaling	9/1308	28/5488	0.204499286904205	0.632521050192075	0.509370928825038	940/1493/2534/3702/3932/5133/5163/10125/7535	9
WP4481	Resistin as a regulator of inflammation	9/1308	28/5488	0.204499286904205	0.632521050192075	0.509370928825038	10000/3569/5293/5294/23236/5333/113026/5336/7124	9
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	9/1308	28/5488	0.204499286904205	0.632521050192075	0.509370928825038	9509/1277/1278/60681/4015/5034/5176/871/4982	9
WP2873	Aryl hydrocarbon receptor pathway	10/1308	32/5488	0.213698732046137	0.653377732462903	0.526166872007126	23491/1545/2939/3553/3726/1728/8140/7040/7124/54658	10
WP4564	Neural crest cell migration during development	10/1308	32/5488	0.213698732046137	0.653377732462903	0.526166872007126	10000/1009/2151/4313/4318/5293/5294/8503/23533/6774	10
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	7/1308	21/5488	0.216074045541081	0.656865098444886	0.528975257354706	196883/2769/4286/23236/5579/5176/7306	7
WP4917	Proximal tubule transport	12/1308	40/5488	0.227485888244354	0.687627798556797	0.553748543752704	5243/1244/9429/6560/6505/6513/6514/142680/6519/8671/340024/11136	12
WP560	TGF-beta receptor signaling	14/1308	48/5488	0.237155644443811	0.699071877691869	0.562964491928355	25805/2022/3624/3694/51176/3976/864/5054/6498/6696/6772/6774/7040/7124	14
WP4673	Male infertility	25/1308	91/5488	0.239450059129061	0.699071877691869	0.562964491928355	5243/27161/338/675/1191/56603/94240/2346/3122/4057/4313/4318/4843/4846/1728/55124/29968/9985/55423/113235/6648/6948/7124/9319/7516	25
WP2118	Arrhythmogenic right ventricular cardiomyopathy	15/1308	52/5488	0.240922436573287	0.699071877691869	0.562964491928355	775/9254/1674/2697/3672/22801/3673/3678/3655/3679/8516/3685/3690/3694/51176	15
WP585	Interferon type I signaling pathways	15/1308	52/5488	0.240922436573287	0.699071877691869	0.562964491928355	2534/3455/10379/3932/27250/5293/5788/8651/9021/6772/6774/6775/6776/7409/7535	15
WP34	Ovarian infertility	6/1308	18/5488	0.243098303332699	0.699071877691869	0.562964491928355	1051/1958/2701/5618/23224/7784	6
WP3599	Transcription factor regulation in adipogenesis	6/1308	18/5488	0.243098303332699	0.699071877691869	0.562964491928355	1051/3569/23175/5106/10891/7124	6
WP3670	Interactions between LOXL4 and oxidative stress pathway	6/1308	18/5488	0.243098303332699	0.699071877691869	0.562964491928355	308/1280/2252/3490/1728/7040	6
WP383	Striated muscle contraction pathway	6/1308	18/5488	0.243098303332699	0.699071877691869	0.562964491928355	1674/7134/7125/7169/7171/7431	6
WP5066	FOXA2 pathway	6/1308	18/5488	0.243098303332699	0.699071877691869	0.562964491928355	1244/338/2938/2939/51085/4547	6
WP2324	AGE/RAGE pathway	18/1308	64/5488	0.249278488597973	0.70944615997825	0.571318929780664	177/249/841/3091/3717/4322/4323/4313/4316/4318/4478/653361/4843/4846/5579/6772/6774/6776	18
WP3971	OSX and miRNAs in tooth development	4/1308	11/5488	0.254977498769341	0.70944615997825	0.571318929780664	249/6927/4854/4855	4
WP4629	Aerobic glycolysis	4/1308	11/5488	0.254977498769341	0.70944615997825	0.571318929780664	2023/3939/5315/6513	4
WP5049	Glycolysis in senescence	4/1308	11/5488	0.254977498769341	0.70944615997825	0.571318929780664	230/2023/3939/5315	4
WP692	Sulfation biotransformation reaction	4/1308	11/5488	0.254977498769341	0.70944615997825	0.571318929780664	6817/6799/6783/6822	4
WP2361	Gastric cancer network 1	7/1308	22/5488	0.256040719390646	0.70944615997825	0.571318929780664	6790/144455/1894/4605/6286/22974/11065	7
WP26	S1P receptor signal transduction	7/1308	22/5488	0.256040719390646	0.70944615997825	0.571318929780664	10000/2771/6300/23236/1901/1903/8877	7
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	5/1308	15/5488	0.275466801158382	0.759317814592016	0.611480709416206	23086/84958/94120/94122/201294	5
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	6/1308	19/5488	0.288743744934048	0.791812743839761	0.63764896466716	941/942/3101/3122/3939/6515	6
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	7/1308	23/5488	0.297914876965148	0.811022203730415	0.653118395168735	1636/59272/183/3606/3569/114548/7124	7
WP536	Calcium regulation in cardiac cells	27/1308	102/5488	0.298797654005942	0.811022203730415	0.653118395168735	196883/309/773/775/811/1131/2697/2701/2702/10052/2771/59345/10681/2786/2869/3760/5570/5350/5577/5579/5996/10636/6004/64407/10287/5999/8490	27
WP4008	NO/cGMP/PKG mediated neuroprotection	8/1308	27/5488	0.304507925935763	0.818172811100131	0.658876798808376	1259/2977/3553/4843/4846/4881/5593/7124	8
WP4561	Cell migration and invasion through p75NTR	8/1308	27/5488	0.304507925935763	0.818172811100131	0.658876798808376	11093/10000/1009/1942/1946/4313/4318/6774	8
WP4565	Neural crest cell migration in cancer	10/1308	35/5488	0.313009318550107	0.830466629004119	0.668777043934856	10000/1009/2151/4313/4318/5293/5294/8503/23533/6774	10
WP1602	Nicotine effect on dopaminergic neurons	4/1308	12/5488	0.315327554621865	0.830466629004119	0.668777043934856	1136/1644/3777/84152	4
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	4/1308	12/5488	0.315327554621865	0.830466629004119	0.668777043934856	249/3655/7040/7124	4
WP4792	Purine metabolism	4/1308	12/5488	0.315327554621865	0.830466629004119	0.668777043934856	100/3614/4860/7498	4
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	5/1308	16/5488	0.328062074353647	0.859748884513005	0.692358124251668	9595/51176/5294/3371/7412	5
WP4217	Ebola virus infection in host	31/1308	120/5488	0.334954731351829	0.865637950763928	0.697100605383694	684/857/858/11314/1508/1514/2316/2318/84868/3108/3111/3112/3119/3122/3123/3134/3384/3672/3673/3678/3655/3685/3690/4240/4791/5293/8503/9021/6772/91937/7099	31
WP5064	7-oxo-C and 7-beta-HC pathways	6/1308	20/5488	0.335943370719692	0.865637950763928	0.697100605383694	23597/8309/1593/1717/2053/3290	6
WP2197	Endothelin pathways	7/1308	24/5488	0.341081249272615	0.865637950763928	0.697100605383694	10203/1906/1909/2769/10681/4846/23236	7
WP4950	16p11.2 distal deletion syndrome	7/1308	24/5488	0.341081249272615	0.865637950763928	0.697100605383694	718/3732/8519/3717/3791/5350/7185	7
WP4823	Genes controlling nephrogenesis	8/1308	28/5488	0.344511381548386	0.865637950763928	0.697100605383694	2118/6928/8516/3791/3913/5155/5159/6469	8
WP3995	Prion disease pathway	9/1308	32/5488	0.346805771128517	0.865637950763928	0.697100605383694	10538/1879/2534/7184/3309/3662/5452/6688/6774	9
WP4222	Phosphodiesterases in neuronal function	9/1308	32/5488	0.346805771128517	0.865637950763928	0.697100605383694	196883/1139/2977/10846/5153/5137/5142/5145/84152	9
WP4746	Thyroid hormones production and peripheral downstream signaling effects	19/1308	72/5488	0.347140990726015	0.865637950763928	0.697100605383694	10000/364/1734/50506/405753/3685/3690/389434/152831/57224/4881/23236/10891/5593/27330/6469/6567/5172/7068	19
WP4331	Neovascularisation processes	10/1308	36/5488	0.348307580398854	0.865637950763928	0.697100605383694	2324/3091/3791/4318/4791/4854/4855/5155/7040/7043	10
WP5220	Metabolic reprogramming in pancreatic cancer	11/1308	40/5488	0.349235723701697	0.865637950763928	0.697100605383694	587/3099/3158/3939/3949/4199/5238/5315/6566/6513/8140	11
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	15/1308	56/5488	0.349558667581561	0.865637950763928	0.697100605383694	84433/940/915/1493/2534/29851/3702/3932/3937/1326/5133/5163/5788/7124/7535	15
WP395	IL-4 signaling pathway	14/1308	52/5488	0.349834886117001	0.865637950763928	0.697100605383694	332/1051/9046/2316/3635/3717/3718/5600/5293/8651/9021/6772/6774/6776	14
WP3958	GPR40 pathway	4/1308	13/5488	0.376632748928349	0.91912212123799	0.740171553905544	23236/5333/113026/5336	4
WP4584	Biomarkers for pyrimidine metabolism disorders	4/1308	13/5488	0.376632748928349	0.91912212123799	0.740171553905544	1152/51251/6241/1890	4
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	4/1308	13/5488	0.376632748928349	0.91912212123799	0.740171553905544	56624/3091/1901/1903	4
WP3874	Canonical and non-canonical TGF-B signaling	5/1308	17/5488	0.381490362353418	0.922450377766681	0.742851807975938	26585/4015/4016/4017/7040	5
WP2858	Ectoderm differentiation	26/1308	102/5488	0.383223778957388	0.922450377766681	0.742851807975938	91653/6347/1004/1896/2274/2534/2627/57476/3801/9079/4061/4772/345557/5362/5420/5452/5783/6386/5269/6469/6498/7903/6781/4982/54521/51222	26
WP2332	Interleukin-11 signaling pathway	11/1308	41/5488	0.383249546736559	0.922450377766681	0.742851807975938	332/2534/3383/3589/3572/3673/3717/9021/6772/6774/7040	11
WP205	IL-7 signaling pathway	7/1308	25/5488	0.384932300496623	0.922450377766681	0.742851807975938	2534/3559/3575/3718/6772/6774/6776	7
WP4963	p53 transcriptional gene network	20/1308	78/5488	0.395646921551178	0.943875167108641	0.76010524933363	8659/6790/6347/898/6376/54541/55332/144455/3383/10379/9636/3976/4688/5366/5371/5268/5054/6513/23657/7124	20
WP2371	Parkinson's disease pathway	8/1308	30/5488	0.425961831275259	0.973526652264081	0.783983671292997	898/1644/120892/5600/6300/9627/23208/9246	8
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	6/1308	22/5488	0.431834993816321	0.973526652264081	0.783983671292997	1244/9429/2052/5600/6300/1728	6
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	6/1308	22/5488	0.431834993816321	0.973526652264081	0.783983671292997	285/2022/2200/2316/4053/5054	6
WP4483	Relationship between inflammation, COX-2 and EGFR	6/1308	22/5488	0.431834993816321	0.973526652264081	0.783983671292997	10000/4312/5293/5294/51365/5743	6
WP4537	Hippo-Yap signaling pathway	6/1308	22/5488	0.431834993816321	0.973526652264081	0.783983671292997	3627/26524/11184/9448/6788/7004	6
WP4533	Transcription co-factors SKI and SKIL protein partners	5/1308	18/5488	0.434718077361387	0.973526652264081	0.783983671292997	26524/23314/6498/6788/7004	5
WP5194	Synthesis of ceramides and 1-deoxyceramides	5/1308	18/5488	0.434718077361387	0.973526652264081	0.783983671292997	53947/2683/1674/259230/8877	5
WP5072	Modulators of TCR signaling and T cell activation	15/1308	59/5488	0.436317709584175	0.973526652264081	0.783983671292997	84433/940/915/921/3702/3932/3937/1326/11184/399/4068/8651/7128/7409/7535	15
WP4239	Epithelial to mesenchymal transition in colorectal cancer	30/1308	121/5488	0.436357822435587	0.973526652264081	0.783983671292997	10000/9076/24146/51208/9075/9073/1282/1284/1285/1286/56648/2305/3091/3678/26524/5600/6300/4313/4318/4854/4855/8828/5293/8503/6678/7040/7043/7481/7474/6935	30
WP4159	GABA receptor signaling	4/1308	14/5488	0.437347845748083	0.973526652264081	0.783983671292997	2555/2562/2564/2568	4
WP4225	Pyrimidine metabolism and related diseases	4/1308	14/5488	0.437347845748083	0.973526652264081	0.783983671292997	51251/5009/6241/1890	4
WP5061	Fatty acid transporters	4/1308	14/5488	0.437347845748083	0.973526652264081	0.783983671292997	2180/2182/2168/2172	4
WP5101	Congenital generalized lipodystrophy (CGL)	4/1308	14/5488	0.437347845748083	0.973526652264081	0.783983671292997	857/2534/3091/23175	4
WP3930	EDA signaling in hair follicle development	3/1308	10/5488	0.439184955908608	0.973526652264081	0.783983671292997	1896/6469/25928	3
WP4846	SARS-CoV-2 and COVID-19 pathway	3/1308	10/5488	0.439184955908608	0.973526652264081	0.783983671292997	59272/1514/340024	3
WP4942	15q13.3 copy number variation syndrome	3/1308	10/5488	0.439184955908608	0.973526652264081	0.783983671292997	1139/2534/871	3
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	3/1308	10/5488	0.439184955908608	0.973526652264081	0.783983671292997	718/629/1675	3
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	13/1308	51/5488	0.443621864497472	0.979281460218486	0.788618033852244	947/1959/2619/3488/51176/4772/22822/864/6275/25928/6925/7040/7474	13
WP3611	Photodynamic therapy-induced AP-1 survival signaling	12/1308	47/5488	0.447582461234219	0.983941608994234	0.792370864385939	602/890/898/2252/1839/3569/3726/5600/6300/4170/4313/7124	12
WP5222	2q13 copy number variation syndrome	11/1308	43/5488	0.451795352054043	0.989115750175929	0.796537614407604	150468/3552/3553/3554/3556/3557/3569/5336/8651/9021/6772	11
WP4148	Splicing factor NOVA regulated synaptic proteins	8/1308	31/5488	0.466515714714794	0.999999999999975	0.805302730510467	288/23705/858/1600/1946/2036/2037/2054	8
WP4540	Hippo signaling regulation pathways	20/1308	81/5488	0.470742948421891	0.999999999999975	0.805302730510467	1009/1012/1001/1003/1004/1969/2261/2321/2324/2771/3791/26524/51176/5159/23236/5577/5579/6788/7004/7010	20
WP408	Oxidative stress response	7/1308	27/5488	0.472424045152163	0.999999999999975	0.805302730510467	1536/3726/4128/4501/1728/6648/7498	7
WP1528	Physiological and pathological hypertrophy of the heart	6/1308	23/5488	0.479100917410853	0.999999999999975	0.805302730510467	183/1906/3572/5600/5579/6774	6
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	6/1308	23/5488	0.479100917410853	0.999999999999975	0.805302730510467	2254/2261/3549/5600/6300/6772	6
WP3645	NAD+ biosynthetic pathways	5/1308	19/5488	0.486851767514008	0.999999999999975	0.805302730510467	952/3620/10135/23475/6999	5
WP49	IL-2 signaling pathway	10/1308	40/5488	0.491999443188543	0.999999999999975	0.805302730510467	2534/3559/3560/3718/3932/9111/9021/6772/6774/6776	10
WP1946	Cori cycle	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	3939/5214/6513/6514	4
WP22	IL-9 signaling pathway	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	3718/6772/6774/6776	4
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	1051/2939/1728/23657	4
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	1004/7040/3371/7431	4
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	699/701/991/1062	4
WP4558	Overview of interferons-mediated signaling pathway	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	3455/10379/3717/6772	4
WP5074	Kallmann syndrome	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	23129/60675/9723/26022	4
WP5149	Lipid metabolism in senescent cells	4/1308	15/5488	0.496213680144338	0.999999999999975	0.805302730510467	240/84647/7941/5743	4
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	9/1308	36/5488	0.498812050216353	0.999999999999975	0.805302730510467	684/3429/8519/10581/10410/3726/5600/6300/6196	9
WP23	B cell receptor signaling pathway	23/1308	95/5488	0.505550728396213	0.999999999999975	0.805302730510467	604/695/84433/973/974/27071/2113/2534/3059/3635/3662/7462/3932/4067/11184/118788/5294/5336/5579/5788/5880/25780/7409	23
WP4542	Leukocyte-intrinsic Hippo pathway functions	8/1308	32/5488	0.506419029243552	0.999999999999975	0.805302730510467	50943/3683/26524/4023/639/83593/6788/7004	8
WP4211	Transcriptional cascade regulating adipogenesis	3/1308	11/5488	0.508262752335833	0.999999999999975	0.805302730510467	1051/1959/10365	3
WP4271	Vitamin B12 disorders	3/1308	11/5488	0.508262752335833	0.999999999999975	0.805302730510467	8029/6947/6948	3
WP4842	Mammalian disorder of sexual development	3/1308	11/5488	0.508262752335833	0.999999999999975	0.805302730510467	2254/5600/5730	3
WP1601	Fluoropyrimidine activity	7/1308	28/5488	0.515061599686755	0.999999999999975	0.805302730510467	9429/8824/6241/7083/1890/7371/7378	7
WP4241	Type 2 papillary renal cell carcinoma	7/1308	28/5488	0.515061599686755	0.999999999999975	0.805302730510467	1513/112399/3091/5155/6513/7040/7043	7
WP5053	Development of ureteric collection system	11/1308	45/5488	0.519351481145835	0.999999999999975	0.805302730510467	653/2118/80144/2719/6928/8516/5915/6091/6469/57216/7481	11
WP3580	Methionine de novo and salvage pathway	5/1308	20/5488	0.537154566445447	0.999999999999975	0.805302730510467	51074/55349/259307/4953/6723	5
WP3640	Imatinib and chronic myeloid leukemia	5/1308	20/5488	0.537154566445447	0.999999999999975	0.805302730510467	5243/9429/2321/5159/11040	5
WP4224	Purine metabolism and related disorders	5/1308	20/5488	0.537154566445447	0.999999999999975	0.805302730510467	100/316/3614/4860/7498	5
WP4630	Measles virus infection	27/1308	114/5488	0.55192893254554	0.999999999999975	0.805302730510467	841/898/940/915/3310/3455/3552/3553/3559/3560/3569/10379/3718/4478/4791/4939/4940/5293/8503/6504/6772/6774/6776/7097/7099/54106/7128	27
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4/1308	16/5488	0.552264215407901	0.999999999999975	0.805302730510467	3157/3949/10891/6319	4
WP368	Mitochondrial long chain fatty acid beta-oxidation	4/1308	16/5488	0.552264215407901	0.999999999999975	0.805302730510467	35/80221/2180/2182	4
WP1591	Heart development	7/1308	29/5488	0.556397168290338	0.999999999999975	0.805302730510467	8553/2627/3670/4772/5308/6469/7424	7
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3/1308	12/5488	0.572574484907155	0.999999999999975	0.805302730510467	3685/3690/7134	3
WP2267	Synaptic vesicle pathway	8/1308	34/5488	0.58293826021088	0.999999999999975	0.805302730510467	773/1759/26052/246213/6570/6507/6532/2054	8
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	11/1308	47/5488	0.584160362145765	0.999999999999975	0.805302730510467	27161/1051/1513/8091/3726/51176/4128/4129/6696/7040/4982	11
WP262	Ebstein-Barr virus LMP1 signaling	5/1308	21/5488	0.585049399462419	0.999999999999975	0.805302730510467	6364/4791/9260/7124/7185	5
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	5/1308	21/5488	0.585049399462419	0.999999999999975	0.805302730510467	841/5600/6300/4170/7124	5
WP304	Kit receptor signaling pathway	13/1308	56/5488	0.59526592086258	0.999999999999975	0.805302730510467	695/2534/3635/3717/3726/4067/4286/5579/8651/6772/6774/6776/7409	13
WP4655	Cytosolic DNA-sensing pathway	13/1308	56/5488	0.59526592086258	0.999999999999975	0.805302730510467	9447/834/843/841/6351/3627/3606/3553/90865/3569/9636/10622/81030	13
WP3298	Melatonin metabolism and effects	7/1308	30/5488	0.596094879555796	0.999999999999975	0.805302730510467	1545/1557/1565/1906/4128/406938/6817	7
WP3858	Toll-like receptor signaling related to MyD88	7/1308	30/5488	0.596094879555796	0.999999999999975	0.805302730510467	4791/7096/7097/7099/10333/51311/54106	7
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	7/1308	30/5488	0.596094879555796	0.999999999999975	0.805302730510467	3283/4318/5163/5293/5294/23236/5579	7
WP3888	VEGFA-VEGFR2 signaling pathway	94/1308	401/5488	0.596333462037075	0.999999999999975	0.805302730510467	57007/23597/8754/9510/56999/301/81575/22899/10973/332/811/813/857/6347/1003/79094/1397/1466/1536/1558/4189/1847/1958/1960/2022/1969/2078/2113/2152/152273/2274/2321/91010/6624/2534/2697/1839/51564/9709/3142/3315/5654/10525/3383/3486/3490/3685/3690/3791/9079/3939/3984/6300/4319/4323/4313/79812/653361/4688/91624/4772/4846/4855/3164/4929/8013/441478/8828/5034/55872/5228/5328/5329/4860/9588/5579/5743/57381/27289/1901/57758/6386/23753/6401/9047/25759/357/6541/6648/6748/6772/6774/7004/8794	94
WP1584	Type II diabetes mellitus	4/1308	17/5488	0.604810016347742	0.999999999999975	0.805302730510467	773/23533/6514/7124	4
WP325	Triacylglyceride synthesis	4/1308	17/5488	0.604810016347742	0.999999999999975	0.805302730510467	56895/2819/4023/80168	4
WP4784	Proteoglycan biosynthesis	4/1308	17/5488	0.604810016347742	0.999999999999975	0.805302730510467	9469/22856/55790/1836	4
WP4912	SARS coronavirus and innate immunity	4/1308	17/5488	0.604810016347742	0.999999999999975	0.805302730510467	59272/3455/10379/6772	4
WP2525	Trans-sulfuration and one-carbon metabolism	6/1308	26/5488	0.611518241874629	0.999999999999975	0.805302730510467	275/875/25902/10797/26227/29968	6
WP3869	Cannabinoid receptor signaling	6/1308	26/5488	0.611518241874629	0.999999999999975	0.805302730510467	1557/1559/1576/5600/6300/5577	6
WP2272	Pathogenic Escherichia coli infection	11/1308	48/5488	0.61508555492706	0.999999999999975	0.805302730510467	10095/9076/2534/3059/23643/7099/79861/7280/10381/84617/7454	11
WP3940	One-carbon metabolism and related pathways	8/1308	35/5488	0.619013023899443	0.999999999999975	0.805302730510467	64902/586/587/55349/56994/1759/2882/6648	8
WP2355	Corticotropin-releasing hormone signaling pathway	16/1308	70/5488	0.622529006431584	0.999999999999975	0.805302730510467	2697/2771/10681/3283/3606/3726/4846/3164/4929/5336/5579/10411/6822/6925/7040/7099	16
WP2064	Neural crest differentiation	13/1308	57/5488	0.623456864723985	0.999999999999975	0.805302730510467	1004/1280/2113/2247/2261/51564/3670/4286/4359/4791/4854/4855/6925	13
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	5/1308	22/5488	0.630112459946565	0.999999999999975	0.805302730510467	857/1051/3717/5618/23508	5
WP357	Fatty acid biosynthesis	5/1308	22/5488	0.630112459946565	0.999999999999975	0.805302730510467	2180/2182/1891/55268/6319	5
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	3/1308	13/5488	0.631357005700797	0.999999999999975	0.805302730510467	8309/4312/5743	3
WP3644	NAD+ metabolism	3/1308	13/5488	0.631357005700797	0.999999999999975	0.805302730510467	952/10135/349565	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	7/1308	31/5488	0.633888802634422	0.999999999999975	0.805302730510467	1636/183/57118/64764/84699/9586/3283	7
WP3941	Oxidative damage response	9/1308	40/5488	0.639127366869392	0.999999999999975	0.805302730510467	715/716/717/719/721/728/7124/7133/7185	9
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	9/1308	40/5488	0.639127366869392	0.999999999999975	0.805302730510467	72/3689/3690/3694/11184/9448/259230/6788/7004	9
WP2533	Glycerophospholipid biosynthetic pathway	6/1308	27/5488	0.65125944093819	0.999999999999975	0.805302730510467	56994/2819/23175/5293/5294/5320	6
WP2643	Nanoparticle-mediated activation of receptor signaling	6/1308	27/5488	0.65125944093819	0.999999999999975	0.805302730510467	10000/1277/3672/5600/6300/5293	6
WP2839	Hair follicle development: organogenesis - part 2 of 3	6/1308	27/5488	0.65125944093819	0.999999999999975	0.805302730510467	1896/3624/3911/51176/6469/7474	6
WP2870	Extracellular vesicle-mediated signaling in recipient cells	6/1308	27/5488	0.65125944093819	0.999999999999975	0.805302730510467	3082/4240/23533/7040/7043/7474	6
WP3998	Prader-Willi and Angelman syndrome	6/1308	27/5488	0.65125944093819	0.999999999999975	0.805302730510467	57194/990/1030/9638/2562/5122	6
WP4758	Nephrotic syndrome	8/1308	36/5488	0.653356159237469	0.999999999999975	0.805302730510467	54443/8542/1285/1286/1493/8029/3913/5420	8
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4/1308	18/5488	0.653407713200986	0.999999999999975	0.805302730510467	2152/2212/3553/114548	4
WP5205	Clock-controlled autophagy in bone metabolism	15/1308	67/5488	0.656422583926847	0.999999999999975	0.805302730510467	393/8553/651/653/8646/115908/1513/3569/3717/4772/10507/5176/7040/4982/7474	15
WP2018	RANKL/RANK signaling pathway	12/1308	54/5488	0.661503382649034	0.999999999999975	0.805302730510467	1513/2274/3383/4067/4286/4772/4791/6688/6772/4982/7185/7412	12
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	9/1308	41/5488	0.670640673347495	0.999999999999975	0.805302730510467	330/841/6347/3569/4318/4791/7124/51330/7185	9
WP4357	NRF2-ARE regulation	5/1308	23/5488	0.67206011065093	0.999999999999975	0.805302730510467	1051/2534/2939/1728/23657	5
WP2895	Differentiation of white and brown adipocyte	3/1308	14/5488	0.68426859477881	0.999999999999975	0.805302730510467	1051/51316/10891	3
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	3/1308	14/5488	0.68426859477881	0.999999999999975	0.805302730510467	1466/283120/5366	3
WP127	IL-5 signaling pathway	8/1308	37/5488	0.68582344188759	0.999999999999975	0.805302730510467	695/1439/3717/4067/5294/6772/6774/6776	8
WP170	Nuclear receptors	6/1308	28/5488	0.688404306734037	0.999999999999975	0.805302730510467	7025/3164/4929/5915/6097/7068	6
WP4149	White fat cell differentiation	6/1308	28/5488	0.688404306734037	0.999999999999975	0.805302730510467	1051/1879/1959/3662/10365/6776	6
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	4/1308	19/5488	0.697822632050847	0.999999999999975	0.805302730510467	3091/3939/5163/6513	4
WP244	Alpha 6 beta 4 signaling pathway	7/1308	33/5488	0.703033606579069	0.999999999999975	0.805302730510467	3655/284217/3909/3911/3913/3915/3918	7
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	5/1308	24/5488	0.71073185728093	0.999999999999975	0.805302730510467	1959/3315/26353/4359/5865	5
WP4925	Unfolded protein response	5/1308	24/5488	0.71073185728093	0.999999999999975	0.805302730510467	841/3309/3553/5366/7494	5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	14/1308	65/5488	0.714322284618823	0.999999999999975	0.805302730510467	2222/2224/3157/3422/3638/3949/23175/4023/4047/4597/6319/10802/9871/6713	14
WP3972	PDGFR-beta pathway	6/1308	29/5488	0.722840951545436	0.999999999999975	0.805302730510467	3717/5159/5579/6772/6774/6776	6
WP5117	Cohesin complex - Cornelia de Lange syndrome	6/1308	29/5488	0.722840951545436	0.999999999999975	0.805302730510467	9212/113130/983/157570/5347/9985	6
WP382	MAPK signaling pathway	43/1308	193/5488	0.723321069744144	0.999999999999975	0.805302730510467	10000/773/775/9254/994/11221/1844/1846/1849/2247/2252/2254/2261/2316/2318/3310/3315/3552/3553/3554/120892/9064/1326/11184/9448/5600/6300/22808/4772/4791/3164/5155/5159/5778/5880/5924/10125/25780/115727/6788/7040/7043/7124	43
WP1971	Integrated cancer pathway	9/1308	43/5488	0.728502462002923	0.999999999999975	0.805302730510467	641/672/841/994/983/1030/4312/5347/6772	9
WP2333	Trans-sulfuration pathway	2/1308	10/5488	0.72893087384761	0.999999999999975	0.805302730510467	875/4357	2
WP3630	NAD metabolism, sirtuins and aging	2/1308	10/5488	0.72893087384761	0.999999999999975	0.805302730510467	3091/10135	2
WP4259	Disorders of folate metabolism and transport	2/1308	10/5488	0.72893087384761	0.999999999999975	0.805302730510467	10840/113235	2
WP4589	Major receptors targeted by epinephrine and norepinephrine	2/1308	10/5488	0.72893087384761	0.999999999999975	0.805302730510467	196883/150	2
WP5050	TCA cycle in senescence	2/1308	10/5488	0.72893087384761	0.999999999999975	0.805302730510467	4199/5163	2
WP5182	Pro-survival signaling of neuroprotectin D1	3/1308	15/5488	0.731282323437428	0.999999999999975	0.805302730510467	330/841/7124	3
WP2037	Prolactin signaling pathway	16/1308	75/5488	0.737003849816427	0.999999999999975	0.805302730510467	116986/2316/2534/3659/3717/4843/5294/5618/6196/8651/9021/6772/6774/6776/7409/7535	16
WP2878	PPAR-alpha pathway	4/1308	20/5488	0.737989648452197	0.999999999999975	0.805302730510467	335/345/983/2168	4
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	4/1308	20/5488	0.737989648452197	0.999999999999975	0.805302730510467	597/3655/4170/5294	4
WP4223	Ras signaling	32/1308	146/5488	0.738748870893248	0.999999999999975	0.805302730510467	10000/1969/2113/2261/2321/2324/59345/10681/2786/3791/8844/283455/22808/5159/5293/8503/51365/84647/5320/5336/5579/5880/8437/64926/5924/10125/25780/115727/83593/25759/7010/7535	32
WP3286	Copper homeostasis	10/1308	48/5488	0.739769431686028	0.999999999999975	0.805302730510467	8754/4493/4494/4495/4496/4500/4501/4502/79689/54739	10
WP4806	EGFR tyrosine kinase inhibitor resistance	17/1308	80/5488	0.747280990746247	0.999999999999975	0.805302730510467	10000/2247/2261/3082/3569/3717/3791/22808/3084/5155/5159/5293/8503/5336/5579/25759/6774	17
WP1544	MicroRNAs in cardiomyocyte hypertrophy	16/1308	76/5488	0.75698234499433	0.999999999999975	0.805302730510467	183/1906/2247/51564/3572/3976/3084/5293/5294/8503/5320/5579/6774/7040/7124/7474	16
WP4815	Glycosaminoglycan degradation	3/1308	16/5488	0.772594194521165	0.999999999999975	0.805302730510467	10855/3373/8692	3
WP4504	Cysteine and methionine catabolism	2/1308	11/5488	0.777968234183561	0.999999999999975	0.805302730510467	875/4357	2
WP4788	Autosomal recessive osteopetrosis pathways	2/1308	11/5488	0.777968234183561	0.999999999999975	0.805302730510467	29887/10312	2
WP4919	Neuroinflammation	2/1308	11/5488	0.777968234183561	0.999999999999975	0.805302730510467	4843/7099	2
WP4947	Nitric oxide metabolism in cystic fibrosis	2/1308	11/5488	0.777968234183561	0.999999999999975	0.805302730510467	4843/4846	2
WP3851	TLR4 signaling and tolerance	5/1308	26/5488	0.778107980389728	0.999999999999975	0.805302730510467	3569/3635/11213/7099/7124	5
WP3303	RAC1/PAK1/p38/MMP2 pathway	13/1308	64/5488	0.789237966859742	0.999999999999975	0.805302730510467	285/9068/332/9046/5600/6300/4313/4843/6774/6776/7010/7075/79931	13
WP710	DNA damage response (only ATM dependent)	20/1308	96/5488	0.791039921583055	0.999999999999975	0.805302730510467	10000/604/3949/51176/197259/4791/5106/5163/5288/5293/5294/8503/23533/5328/5366/5880/6648/7040/7481/7474	20
WP3915	Angiopoietin-like protein 8 regulatory pathway	26/1308	123/5488	0.791214472472992	0.999999999999975	0.805302730510467	64240/64241/1576/1734/2203/4023/9064/1326/11184/9448/5600/6300/51085/5105/5288/5293/5294/8503/23433/6196/27330/6319/25759/6567/6513/7068	26
WP4666	Hepatitis B infection	28/1308	132/5488	0.791967027921591	0.999999999999975	0.805302730510467	10000/332/843/841/64764/84699/9586/1959/1960/3569/3717/3718/5600/6300/4318/4772/5293/8503/5579/6772/6774/6775/6776/7040/7043/7097/7099/7124	28
WP4290	Metabolic reprogramming in colon cancer	8/1308	41/5488	0.795568528967962	0.999999999999975	0.805302730510467	229/2023/3101/3939/5315/29968/5831/6513	8
WP3845	Canonical and non-canonical Notch signaling	4/1308	22/5488	0.805945173711947	0.999999999999975	0.805302730510467	51176/4237/4854/4855	4
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4/1308	22/5488	0.805945173711947	0.999999999999975	0.805302730510467	3553/3569/10135/6513	4
WP4787	Osteoblast differentiation and related diseases	18/1308	88/5488	0.808193434664045	0.999999999999975	0.805302730510467	2247/2252/2254/2261/3549/5600/6300/4854/4855/5288/5293/5294/8503/23533/5579/6772/7481/7474	18
WP100	Glutathione metabolism	3/1308	17/5488	0.808547946986899	0.999999999999975	0.805302730510467	290/2687/2938	3
WP3527	Pre-implantation embryo	6/1308	32/5488	0.809765459697099	0.999999999999975	0.805302730510467	366/1045/1958/3662/5460/7004	6
WP2513	Nanoparticle triggered regulated necrosis	2/1308	12/5488	0.819046984038842	0.999999999999975	0.805302730510467	841/7124	2
WP47	Hedgehog signaling pathway	2/1308	12/5488	0.819046984038842	0.999999999999975	0.805302730510467	3549/6469	2
WP5173	Disorders of galactose metabolism 	2/1308	12/5488	0.819046984038842	0.999999999999975	0.805302730510467	8908/6514	2
WP2363	Gastric cancer network 2	5/1308	28/5488	0.832705212850877	0.999999999999975	0.805302730510467	29028/79075/51316/255488/11065	5
WP3982	miRNA regulation of p53 pathway in prostate cancer	4/1308	23/5488	0.834131502777425	0.999999999999975	0.805302730510467	841/192668/5366/5054	4
WP410	Exercise-induced circadian regulation	8/1308	43/5488	0.838392517023233	0.999999999999975	0.805302730510467	1051/50486/2947/9709/3108/3422/11030/10381	8
WP4288	MTHFR deficiency	3/1308	18/5488	0.839575993744081	0.999999999999975	0.805302730510467	55349/56994/259230	3
WP5103	Progeria-associated lipodystrophy	3/1308	18/5488	0.839575993744081	0.999999999999975	0.805302730510467	2200/5965/7040	3
WP5181	Roles of ceramides in the development of insulin resistance	3/1308	18/5488	0.839575993744081	0.999999999999975	0.805302730510467	2180/7124/7185	3
WP3931	Embryonic stem cell pluripotency pathways	16/1308	81/5488	0.841448443505305	0.999999999999975	0.805302730510467	90/10000/2247/2252/2254/2261/6927/3572/3976/6300/5155/5159/5293/6774/7481/7474	16
WP5224	2q37 copy number variation syndrome	19/1308	95/5488	0.843038378252474	0.999999999999975	0.805302730510467	57007/10123/10203/1058/1293/6373/27128/27185/55355/3553/3690/129807/23178/5133/64284/25992/7124/54658/54575	19
WP2359	Parkin-ubiquitin proteasomal system pathway	11/1308	58/5488	0.84907796983149	0.999999999999975	0.805302730510467	834/841/898/3309/3310/9627/79861/7280/10381/84617/9246	11
WP4962	Airway smooth muscle cell contraction	2/1308	13/5488	0.85317243464576	0.999999999999975	0.805302730510467	952/23236	2
WP4312	Rett syndrome causing genes	6/1308	34/5488	0.854765266170294	0.999999999999975	0.805302730510467	3097/3766/23314/85358/23224/6925	6
WP4971	Phosphoinositides metabolism	8/1308	44/5488	0.856982223300519	0.999999999999975	0.805302730510467	3635/5288/5293/5294/23236/5333/113026/5336	8
WP4698	Vitamin D-sensitive calcium signaling in depression	4/1308	24/5488	0.858811431876723	0.999999999999975	0.805302730510467	775/1593/1594/7166	4
WP51	Regulation of actin cytoskeleton	23/1308	115/5488	0.862139060332354	0.999999999999975	0.805302730510467	9459/1131/81624/2149/2247/2252/2254/2261/3672/3984/22808/4478/5155/5159/5288/5293/5294/8503/23533/5880/7409/7429/7454	23
WP4906	3q29 copy number variation syndrome	9/1308	50/5488	0.875052420380356	0.999999999999975	0.805302730510467	84984/3091/375387/80235/8503/30061/123264/6776/7040	9
WP4844	Influence of laminopathies on Wnt signaling	5/1308	30/5488	0.875806826838843	0.999999999999975	0.805302730510467	27161/1051/8091/51176/6696	5
WP5121	Sphingolipid metabolism in senescence	4/1308	25/5488	0.880285706098243	0.999999999999975	0.805302730510467	23236/5579/1901/8877	4
WP53	ID signaling pathway	2/1308	14/5488	0.881323074623585	0.999999999999975	0.805302730510467	898/2004	2
WP254	Apoptosis	15/1308	80/5488	0.888735253120941	0.999999999999975	0.805302730510467	330/332/834/843/841/3002/3659/3662/4049/4170/5366/5551/7124/7133/7185	15
WP314	Fas ligand pathway and stress induction of heat shock proteins	7/1308	41/5488	0.889265832808098	0.999999999999975	0.805302730510467	397/843/841/3315/3552/8767/7124	7
WP4255	Non-small cell lung cancer	12/1308	66/5488	0.893501557831788	0.999999999999975	0.805302730510467	10000/841/3718/5163/5293/8503/5336/5579/5915/83593/6774/6776	12
WP1422	Sphingolipid pathway	4/1308	26/5488	0.898863474408882	0.999999999999975	0.805302730510467	56624/9514/259230/8877	4
WP5038	Mitochondrial immune response to SARS-CoV-2	4/1308	26/5488	0.898863474408882	0.999999999999975	0.805302730510467	1636/59272/1514/4791	4
WP1772	Apoptosis modulation and signaling	15/1308	81/5488	0.899482255306312	0.999999999999975	0.805302730510467	597/330/332/664/834/843/841/3554/4170/4671/8682/5366/5783/8794/7133	15
WP2038	Microtubule cytoskeleton regulation	7/1308	42/5488	0.903529428244897	0.999999999999975	0.805302730510467	9212/983/2151/11004/3984/6774/10420	7
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	2/1308	15/5488	0.904406267113763	0.999999999999975	0.805302730510467	51176/6925	2
WP3927	BMP signaling in eyelid development	2/1308	15/5488	0.904406267113763	0.999999999999975	0.805302730510467	5308/6469	2
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/1308	15/5488	0.904406267113763	0.999999999999975	0.805302730510467	2254/5600	2
WP4970	Galanin receptor pathway	2/1308	15/5488	0.904406267113763	0.999999999999975	0.805302730510467	3569/10891	2
WP2828	Bladder cancer	6/1308	37/5488	0.905540476039525	0.999999999999975	0.805302730510467	2261/1839/4312/4313/4318/1890	6
WP4905	1q21.1 copy number variation syndrome	3/1308	21/5488	0.907904874818394	0.999999999999975	0.805302730510467	2330/2697/2702	3
WP3996	Ethanol effects on histone modifications	4/1308	27/5488	0.914850653627567	0.999999999999975	0.805302730510467	126/216/8854/51564	4
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	6/1308	38/5488	0.918663799445784	0.999999999999975	0.805302730510467	10000/775/116443/5293/8503/85358	6
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	5/1308	33/5488	0.92257898323333	0.999999999999975	0.805302730510467	3455/10379/4939/4940/6772	5
WP4875	Disruption of postsynaptic signaling by CNV	2/1308	16/5488	0.923236563198419	0.999999999999975	0.805302730510467	57555/9378	2
WP4482	Vitamin D in inflammatory diseases	3/1308	22/5488	0.924003774993096	0.999999999999975	0.805302730510467	3569/4772/7124	3
WP143	Fatty acid beta-oxidation	4/1308	28/5488	0.928541560423682	0.999999999999975	0.805302730510467	35/2180/2182/4023	4
WP4016	DNA IR-damage and cellular response via ATR	13/1308	75/5488	0.933155382551361	0.999999999999975	0.805302730510467	604/672/675/8318/983/63967/9156/2175/2237/2305/5347/5371/5965	13
WP4313	Ferroptosis	10/1308	60/5488	0.933188529034151	0.999999999999975	0.805302730510467	2180/2182/246/875/1536/1803/2222/3315/30061/23657	10
WP4249	Hedgehog signaling pathway	5/1308	34/5488	0.934271003416612	0.999999999999975	0.805302730510467	91653/2619/64399/3549/6469	5
WP500	Glycogen synthesis and degradation	5/1308	34/5488	0.934271003416612	0.999999999999975	0.805302730510467	8908/3099/3101/80201/5523	5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	1/1308	10/5488	0.934460070420172	0.999999999999975	0.805302730510467	672	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/1308	10/5488	0.934460070420172	0.999999999999975	0.805302730510467	51311	1
WP4566	Translation inhibitors in chronically activated PDGFRA cells	7/1308	45/5488	0.937268708935134	0.999999999999975	0.805302730510467	10000/27250/5163/5294/8503/11040/6196	7
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/1308	17/5488	0.938528378693289	0.999999999999975	0.805302730510467	3685/3690	2
WP2586	Aryl hydrocarbon receptor pathway	6/1308	41/5488	0.948938493594766	0.999999999999975	0.805302730510467	1545/4023/135112/1728/5743/7124	6
WP466	DNA replication	6/1308	41/5488	0.948938493594766	0.999999999999975	0.805302730510467	8318/990/8317/55388/4998/23594	6
WP186	Homologous recombination	1/1308	11/5488	0.950109254043833	0.999999999999975	0.805302730510467	675	1
WP2290	RalA downstream regulated genes	1/1308	11/5488	0.950109254043833	0.999999999999975	0.805302730510467	5880	1
WP3871	Valproic acid pathway	1/1308	11/5488	0.950109254043833	0.999999999999975	0.805302730510467	1559	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/1308	11/5488	0.950109254043833	0.999999999999975	0.805302730510467	6750	1
WP3933	Kennedy pathway from sphingolipids	1/1308	11/5488	0.950109254043833	0.999999999999975	0.805302730510467	56994	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/1308	11/5488	0.950109254043833	0.999999999999975	0.805302730510467	604	1
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	4/1308	30/5488	0.950121912015351	0.999999999999975	0.805302730510467	4846/5163/5294/8503	4
WP2857	Mesodermal commitment pathway	20/1308	112/5488	0.95029639063678	0.999999999999975	0.805302730510467	90/92/8728/10973/57198/8553/55704/8646/1466/2627/8091/3624/3717/51176/5308/5460/5915/6925/55809/10451	20
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/1308	18/5488	0.95089742681194	0.999999999999975	0.805302730510467	2683/8877	2
WP4722	Glycerolipids and glycerophospholipids	2/1308	18/5488	0.95089742681194	0.999999999999975	0.805302730510467	56895/56994	2
WP4321	Thermogenesis	16/1308	93/5488	0.953368843427075	0.999999999999975	0.805302730510467	2180/2182/196883/656/64764/84699/9586/2641/152831/5600/6300/4881/10891/5593/6196/27330	16
WP179	Cell cycle	20/1308	113/5488	0.955170593795667	0.999999999999975	0.805302730510467	699/890/891/898/8556/991/994/8318/990/8317/983/1030/10459/4998/23594/9088/5347/7040/7043/7272	20
WP35	G protein signaling pathways	13/1308	79/5488	0.958620298125129	0.999999999999975	0.805302730510467	196883/9472/9465/2769/2771/10681/2786/3760/5153/5137/5142/5577/5579	13
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	2/1308	19/5488	0.960867153606102	0.999999999999975	0.805302730510467	3002/4170	2
WP2023	Cell differentiation - expanded index	1/1308	12/5488	0.962024005862468	0.999999999999975	0.805302730510467	6774	1
WP2853	Endoderm differentiation	19/1308	110/5488	0.963376039100765	0.999999999999975	0.805302730510467	10973/57198/1844/1846/1847/2627/3087/6928/3915/51176/10459/5460/23682/6772/30009/6925/7040/55809/10451	19
WP2112	IL-17 signaling pathway	3/1308	26/5488	0.965776863598506	0.999999999999975	0.805302730510467	1051/3717/6774	3
WP4838	Regucalcin in proximal tubule epithelial kidney cells	3/1308	26/5488	0.965776863598506	0.999999999999975	0.805302730510467	841/5153/7040	3
WP5102	Familial partial lipodystrophy (FPLD)	3/1308	26/5488	0.965776863598506	0.999999999999975	0.805302730510467	10365/4023/5396	3
WP3584	MECP2 and associated Rett syndrome	7/1308	49/5488	0.965889356675455	0.999999999999975	0.805302730510467	604/2247/2289/2530/2893/6750/6890	7
WP481	Insulin signaling	27/1308	150/5488	0.967085671942701	0.999999999999975	0.805302730510467	1958/30846/5167/9064/1326/11184/9448/5600/6300/5288/5293/5294/8503/5579/5880/5967/57381/23433/6196/27330/10110/25759/6513/8651/9021/57761/7494	27
WP1403	AMP-activated protein kinase (AMPK) signaling	8/1308	55/5488	0.968757468291803	0.999999999999975	0.805302730510467	890/891/5209/5293/5294/8503/23236/55437	8
WP2507	Nanomaterial induced apoptosis	2/1308	20/5488	0.968877712922631	0.999999999999975	0.805302730510467	841/5551	2
WP4725	Sphingolipid metabolism overview	2/1308	20/5488	0.968877712922631	0.999999999999975	0.805302730510467	259230/8877	2
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	10/1308	66/5488	0.970218071964597	0.999999999999975	0.805302730510467	467/80319/283120/51176/5328/5176/6423/6425/7481/7474	10
WP4659	Gastrin signaling pathway	18/1308	107/5488	0.970558178720468	0.999999999999975	0.805302730510467	302/330/332/960/1113/9076/1958/2534/51564/3067/3717/4316/8503/5743/5054/6774/6925/7032	18
WP231	TNF-alpha signaling pathway	15/1308	92/5488	0.970876082751005	0.999999999999975	0.805302730510467	330/841/6347/2752/3569/8844/283455/1326/4791/5347/6401/7124/7128/7133/7185	15
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	1/1308	13/5488	0.971094970130527	0.999999999999975	0.805302730510467	25939	1
WP5037	Riboflavin and CoQ disorders	1/1308	13/5488	0.971094970130527	0.999999999999975	0.805302730510467	55065	1
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4/1308	33/5488	0.971490003248516	0.999999999999975	0.805302730510467	3488/5163/5294/10891	4
WP4657	22q11.2 copy number variation syndrome	13/1308	82/5488	0.97167045361919	0.999999999999975	0.805302730510467	8854/8659/8318/8646/9076/56603/4942/5308/5347/5625/6097/6469/7450	13
WP2636	Common pathways underlying drug addiction	3/1308	27/5488	0.972142639844873	0.999999999999975	0.805302730510467	72/2893/5579	3
WP2526	PDGF pathway	5/1308	39/5488	0.972153898603659	0.999999999999975	0.805302730510467	5155/5159/6772/6774/7409	5
WP4205	MET in type 1 papillary renal cell carcinoma	7/1308	51/5488	0.975188143548518	0.999999999999975	0.805302730510467	10000/2113/3082/3718/5293/8503/6774	7
WP3658	Wnt/beta-catenin signaling pathway in leukemia	2/1308	21/5488	0.975295906407288	0.999999999999975	0.805302730510467	51176/5371	2
WP4686	Leucine, isoleucine and valine metabolism	2/1308	21/5488	0.975295906407288	0.999999999999975	0.805302730510467	586/587	2
WP4726	Sphingolipid metabolism: integrated pathway	2/1308	21/5488	0.975295906407288	0.999999999999975	0.805302730510467	259230/8877	2
WP313	Hepatocyte growth factor receptor signaling	4/1308	34/5488	0.976452536559437	0.999999999999975	0.805302730510467	3082/3672/11184/6774	4
WP268	Notch signaling	5/1308	40/5488	0.976717897105696	0.999999999999975	0.805302730510467	1840/151636/4242/4854/4855	5
WP4830	GDNF/RET signaling axis	1/1308	14/5488	0.978000500554138	0.999999999999975	0.805302730510467	26585	1
WP4928	MAPK pathway in congenital thyroid cancer	1/1308	14/5488	0.978000500554138	0.999999999999975	0.805302730510467	8844	1
WP5200	Dravet syndrome	1/1308	14/5488	0.978000500554138	0.999999999999975	0.805302730510467	5600	1
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	7/1308	52/5488	0.978905267454056	0.999999999999975	0.805302730510467	843/841/3627/9636/5600/6300/7124	7
WP4861	Endoplasmic reticulum stress response in coronavirus infection	5/1308	41/5488	0.980576147593325	0.999999999999975	0.805302730510467	3309/26051/84152/79660/7494	5
WP2516	ATM signaling pathway	4/1308	35/5488	0.980593997991537	0.999999999999975	0.805302730510467	672/891/898/983	4
WP524	G13 signaling pathway	4/1308	35/5488	0.980593997991537	0.999999999999975	0.805302730510467	397/3984/5293/7454	4
WP2261	Glioblastoma signaling pathways	12/1308	80/5488	0.981554727238049	0.999999999999975	0.805302730510467	10000/672/675/898/1030/54206/5159/5288/5293/5294/5336/5579	12
WP195	IL-1 signaling pathway	7/1308	53/5488	0.982101575409749	0.999999999999975	0.805302730510467	6347/3552/3553/3554/3556/3656/11213	7
WP2795	Cardiac hypertrophic response	7/1308	53/5488	0.982101575409749	0.999999999999975	0.805302730510467	2247/51564/11184/3084/5320/7040/7124	7
WP1545	miRNAs involved in DNA damage response	1/1308	15/5488	0.983257231514165	0.999999999999975	0.805302730510467	898	1
WP1742	TP53 network	1/1308	15/5488	0.983257231514165	0.999999999999975	0.805302730510467	5366	1
WP3594	Circadian rhythm genes	24/1308	142/5488	0.983384231631582	0.999999999999975	0.805302730510467	100/56938/8553/1390/1644/1958/1960/50865/6928/3569/4547/10135/4843/5371/10891/5551/5593/60675/5730/6097/5054/150094/6532/7166	24
WP3878	ATM signaling in development and disease 	5/1308	42/5488	0.98382877954471	0.999999999999975	0.805302730510467	9212/699/983/8851/3315	5
WP399	Wnt signaling pathway and pluripotency	11/1308	76/5488	0.984707069113341	0.999999999999975	0.805302730510467	960/3949/51176/120892/4316/5328/5460/5523/5579/7481/7474	11
WP2637	Interleukin-1 (IL-1) structural pathway	6/1308	49/5488	0.986723354173286	0.999999999999975	0.805302730510467	3552/3554/3556/3656/1326/5600	6
WP5085	Vasopressin-regulated water reabsorption	4/1308	37/5488	0.9869010687994	0.999999999999975	0.805302730510467	397/64764/84699/9586	4
WP61	Notch signaling pathway	7/1308	55/5488	0.987188960390954	0.999999999999975	0.805302730510467	1840/3091/3717/3932/4854/4855/6774	7
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	1/1308	16/5488	0.987258609401882	0.999999999999975	0.805302730510467	5105	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/1308	16/5488	0.987258609401882	0.999999999999975	0.805302730510467	10125	1
WP3965	Lipid metabolism pathway	2/1308	24/5488	0.987768423079879	0.999999999999975	0.805302730510467	10000/5577	2
WP4150	Wnt signaling in kidney disease	2/1308	24/5488	0.987768423079879	0.999999999999975	0.805302730510467	7481/7474	2
WP4521	Glycosylation and related congenital defects	2/1308	24/5488	0.987768423079879	0.999999999999975	0.805302730510467	2683/79644	2
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	8/1308	61/5488	0.987834701363817	0.999999999999975	0.805302730510467	80319/51176/5328/5176/6423/6425/7481/7474	8
WP45	G1 to S cell cycle control	8/1308	61/5488	0.987834701363817	0.999999999999975	0.805302730510467	891/898/8318/983/1030/84699/4998/23594	8
WP391	Mitochondrial gene expression	1/1308	17/5488	0.990304248821169	0.999999999999975	0.805302730510467	10891	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/1308	17/5488	0.990304248821169	0.999999999999975	0.805302730510467	1958	1
WP366	TGF-beta signaling pathway	20/1308	127/5488	0.990860124137418	0.999999999999975	0.805302730510467	467/857/983/1030/1278/2113/50943/3673/3690/3726/11184/4312/4321/5163/5371/150094/6498/7040/3371/6935	20
WP428	Wnt signaling	12/1308	85/5488	0.99093516274993	0.999999999999975	0.805302730510467	80319/51176/4772/5328/23236/5579/5176/6423/6425/57216/7481/7474	12
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4/1308	39/5488	0.99122539234415	0.999999999999975	0.805302730510467	196883/23224/7040/7043	4
WP2446	Retinoblastoma gene in cancer	12/1308	86/5488	0.992171987287291	0.999999999999975	0.805302730510467	54443/890/891/898/994/8318/8317/983/24137/4998/6241/7272	12
WP4022	Pyrimidine metabolism	10/1308	75/5488	0.992194332827777	0.999999999999975	0.805302730510467	1503/5167/953/956/10622/6241/7083/1890/7371/7378	10
WP4874	CAMKK2 pathway	3/1308	33/5488	0.992233772758916	0.999999999999975	0.805302730510467	1131/3383/7412	3
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	1/1308	18/5488	0.992622297174653	0.999999999999975	0.805302730510467	55872	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/1308	18/5488	0.992622297174653	0.999999999999975	0.805302730510467	22808	1
WP4932	7q11.23 copy number variation syndrome	11/1308	82/5488	0.993753424404742	0.999999999999975	0.805302730510467	64756/695/9076/2006/2200/7462/3984/51085/3084/5313/9246	11
WP384	Apoptosis modulation by HSP70	1/1308	19/5488	0.99438647181735	0.999999999999975	0.805302730510467	841	1
WP363	Wnt signaling pathway	5/1308	48/5488	0.9948230532334	0.999999999999975	0.805302730510467	2697/51176/5579/6925/7010	5
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	7/1308	61/5488	0.995496329242581	0.999999999999975	0.805302730510467	898/1958/2771/3717/23236/6772/6774	7
WP4685	Melanoma	7/1308	61/5488	0.995496329242581	0.999999999999975	0.805302730510467	10000/2113/3791/4286/5293/8503/25759	7
WP707	DNA damage response	7/1308	62/5488	0.996237683536413	0.999999999999975	0.805302730510467	672/841/891/898/983/5366/5371	7
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	8/1308	68/5488	0.996262236877789	0.999999999999975	0.805302730510467	10000/332/51176/5366/5743/5880/7040/7043	8
WP722	Serotonin HTR1 group and FOS pathway	2/1308	29/5488	0.996311339519188	0.999999999999975	0.805302730510467	2771/10125	2
WP2034	Leptin signaling pathway	9/1308	74/5488	0.996354308038066	0.999999999999975	0.805302730510467	2534/3553/3557/3717/4846/5336/9021/6772/6774	9
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	17/1308	119/5488	0.996673034244845	0.999999999999975	0.805302730510467	249/8851/1958/1959/2534/2562/3717/3738/8844/653361/4688/25759/6696/6772/6774/6776/10451	17
WP4674	Head and neck squamous cell carcinoma	8/1308	69/5488	0.99686150482456	0.999999999999975	0.805302730510467	84962/10000/841/54541/2261/4791/5294/23533	8
WP3959	DNA IR-double strand breaks and cellular response via ATM	5/1308	51/5488	0.997135519209087	0.999999999999975	0.805302730510467	641/672/675/9156/6788	5
WP4262	Breast cancer pathway	16/1308	115/5488	0.99726812525493	0.999999999999975	0.805302730510467	10000/672/675/2247/2252/2254/2324/51176/4791/4854/4855/5293/8503/25759/7481/7474	16
WP4263	Pancreatic adenocarcinoma pathway	10/1308	82/5488	0.997478467441719	0.999999999999975	0.805302730510467	10000/9459/675/5293/8503/5880/6772/6774/7040/7043	10
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	1/1308	22/5488	0.997528102996905	0.999999999999975	0.805302730510467	51176	1
WP2447	Amyotrophic lateral sclerosis (ALS)	2/1308	31/5488	0.997733774016407	0.999999999999975	0.805302730510467	834/7124	2
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	2/1308	31/5488	0.997733774016407	0.999999999999975	0.805302730510467	51564/4772	2
WP3981	miRNA regulation of prostate cancer signaling pathways	2/1308	31/5488	0.997733774016407	0.999999999999975	0.805302730510467	10000/5159	2
WP5202	Alstrom syndrome	2/1308	31/5488	0.997733774016407	0.999999999999975	0.805302730510467	84984/26052	2
WP673	ErbB signaling pathway	9/1308	77/5488	0.99781412179426	0.999999999999975	0.805302730510467	10000/1839/3084/5293/8503/5336/5579/25759/6776	9
WP1530	miRNA regulation of DNA damage response	7/1308	65/5488	0.997825689700911	0.999999999999975	0.805302730510467	672/841/891/898/983/5366/5371	7
WP437	EGF/EGFR signaling pathway	23/1308	154/5488	0.997838809776189	0.999999999999975	0.805302730510467	50807/6790/857/858/1759/9046/54206/2697/3635/3717/11184/4605/4846/5359/5579/7837/6196/9047/6772/6774/6776/7409/10451	23
WP4155	Endometrial cancer	6/1308	59/5488	0.997915961272829	0.999999999999975	0.805302730510467	10000/2247/2261/51176/5293/8503	6
WP531	DNA mismatch repair	1/1308	23/5488	0.998119621708952	0.999999999999975	0.805302730510467	9156	1
WP5180	DYRK1A	5/1308	54/5488	0.998435305662896	0.999999999999975	0.805302730510467	1759/2247/3092/26524/4772	5
WP400	p38 MAPK signaling pathway	2/1308	33/5488	0.998612766248134	0.999999999999975	0.805302730510467	3315/6772	2
WP183	Proteasome degradation	5/1308	55/5488	0.998724314500451	0.999999999999975	0.805302730510467	3134/5684/5696/5698/5721	5
WP4949	16p11.2 proximal deletion syndrome	6/1308	62/5488	0.998838097194625	0.999999999999975	0.805302730510467	283897/841/11151/3486/4478/23475	6
WP1471	Target of rapamycin (TOR) signaling	2/1308	34/5488	0.99891600231581	0.999999999999975	0.805302730510467	54541/3422	2
WP4549	Fragile X syndrome	11/1308	93/5488	0.998940214341521	0.999999999999975	0.805302730510467	116986/27161/7915/1759/1979/54869/2534/4318/5163/23236/6566	11
WP623	Oxidative phosphorylation	2/1308	36/5488	0.999339633822728	0.999999999999975	0.805302730510467	3002/56901	2
WP3676	BDNF-TrkB signaling	1/1308	28/5488	0.999521431274945	0.999999999999975	0.805302730510467	5294	1
WP138	Androgen receptor signaling pathway	8/1308	81/5488	0.999651744216492	0.999999999999975	0.805302730510467	672/811/857/898/2274/2316/8431/6774	8
WP4396	Nonalcoholic fatty liver disease	17/1308	135/5488	0.999687302459755	0.999999999999975	0.805302730510467	10000/841/6347/3552/3553/3569/51085/56901/9971/5293/8503/5313/9021/7040/7124/7412/7494	17
WP4752	Base excision repair	1/1308	31/5488	0.999789591529108	0.999999999999975	0.805302730510467	2237	1
WP422	MAPK cascade	1/1308	33/5488	0.999878376614754	0.999999999999975	0.805302730510467	6300	1
WP3680	Physico-chemical features and toxicity-associated pathways	3/1308	52/5488	0.999900957444497	0.999999999999975	0.805302730510467	5294/6776/7481	3
WP2369	Histone modifications	1/1308	35/5488	0.999929713724266	0.999999999999975	0.805302730510467	80854	1
WP3651	Pathways affected in adenoid cystic carcinoma	3/1308	57/5488	0.999970174264316	0.999999999999975	0.805302730510467	672/93986/29128	3
WP4656	Joubert syndrome	4/1308	66/5488	0.999976336816785	0.999999999999975	0.805302730510467	27077/2316/5145/6469	4
WP5124	Alzheimer's disease	27/1308	208/5488	0.999976715733531	0.999999999999975	0.805302730510467	177/10000/775/841/8851/1139/1536/3552/3553/3569/3800/4023/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7481/7474/7494	27
WP2059	Alzheimer's disease and miRNA effects	27/1308	210/5488	0.999982738722336	0.999999999999975	0.805302730510467	177/10000/775/841/8851/1139/1536/3552/3553/3569/3800/4023/4311/4843/5293/8503/23236/5684/5743/7124/79861/7280/10381/84617/7481/7474/7494	27
WP405	Eukaryotic transcription initiation	1/1308	41/5488	0.99998645348828	0.999999999999975	0.805302730510467	2966	1
WP1541	Energy metabolism	1/1308	43/5488	0.999992178710208	0.999999999999975	0.805302730510467	10891	1
WP4753	Nucleotide excision repair	1/1308	43/5488	0.999992178710208	0.999999999999975	0.805302730510467	2966	1
WP107	Translation factors	1/1308	46/5488	0.999996570225181	0.999999999999975	0.805302730510467	1979	1
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	2/1308	57/5488	0.999996829324786	0.999999999999975	0.805302730510467	672/2966	2
WP4536	Genes related to primary cilium development (based on CRISPR)	4/1308	84/5488	0.999999667721074	0.999999999999975	0.805302730510467	27077/23552/84984/51715	4
WP4946	DNA repair pathways, full network	6/1308	110/5488	0.999999966292706	0.999999999999975	0.805302730510467	672/675/9156/2175/2237/2966	6
WP4803	Ciliopathies	7/1308	126/5488	0.999999994852578	0.999999999999975	0.805302730510467	122481/27077/84984/1259/84662/4751/51715	7
WP477	Cytoplasmic ribosomal proteins	2/1308	84/5488	0.999999997339311	0.999999999999975	0.805302730510467	6196/27330	2
WP4352	Ciliary landscape	9/1308	194/5488	0.999999999999975	0.999999999999975	0.805302730510467	26286/875/9859/30845/128239/3934/55388/2040/7431	9
